{"meta":{"query_hash":"db851563d35d","filters":{"venue":"Bladder Cancer"},"cohort_total":54,"direct_labels_cover":0,"predictions_cover":54,"exported":54,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/db851563d35d","api":"https://metacan.xera.ac/api/v1/cohort?venue=Bladder+Cancer"},"results":[{"id":"W1621391416","doi":"10.3233/blc-150018","title":"The Role of Population-Based Observational Research in Bladder Cancer","year":2015,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Observational study; Bladder cancer; Psychological intervention; Population; Clinical trial; Clinical Practice; Cancer; Medicine; Translational research; Family medicine; Nursing; Environmental health; Pathology; Internal medicine","score_opus":0.2850106155848942,"score_gpt":0.491273960381424,"score_spread":0.2062633447965298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1621391416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010999139,0.99307495,8.855875e-7,0.0007823991,0.00045883426,0.0021112638,0.00049449666,0.000029560166,0.002937618],"genre_scores_gemma":[0.0009679185,0.99196386,0.00006287206,0.0001789261,0.00089913013,0.003263433,0.00042350532,0.00012782453,0.0021125448],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959056,0.0003831121,0.00096933095,0.0006294038,0.0014489488,0.00066362217],"domain_scores_gemma":[0.99737066,0.0005510512,0.00035955067,0.00077236356,0.00072976697,0.0002165961],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008672373,0.00047076432,0.0015390079,0.0003916907,0.00016869957,0.000041863303,0.0003876189,0.0004122144,0.00074056286],"category_scores_gemma":[0.00009679214,0.00030283723,0.0004020557,0.0012959338,0.00019418357,0.000081399514,0.00008453814,0.0008389726,0.000041774663],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015208863,0.00021235681,0.012917924,0.0027672318,0.0007316535,0.000011722208,0.000097821074,0.00003915119,0.0000010546285,0.00028429658,0.0066156965,0.976169],"study_design_scores_gemma":[0.0011804132,0.00010474709,0.004090201,0.008062308,0.0007924492,0.0000042602937,0.000061000588,0.00006560477,0.000007926053,0.000715437,0.9846436,0.00027207224],"about_ca_topic_score_codex":0.014973501,"about_ca_topic_score_gemma":0.0039062784,"teacher_disagreement_score":0.9780279,"about_ca_system_score_codex":0.0015017664,"about_ca_system_score_gemma":0.0075379,"threshold_uncertainty_score":0.99994236},"labels":[],"label_agreement":null},{"id":"W1831939955","doi":"10.1002/9781118674826.ch3","title":"Utility of urine biomarkers","year":2015,"lang":"en","type":"other","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Mount Sinai Hospital","funders":"","keywords":"Cystoscopy; Bladder cancer; Urine cytology; Medicine; Urine; Cytology; Urinary system; Urology; Cancer; Urinary bladder; Internal medicine; Pathology","score_opus":0.035585582907429025,"score_gpt":0.32316588186901146,"score_spread":0.28758029896158244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1831939955","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014026614,0.027086742,0.0000105250865,0.00025995597,0.00070180447,0.00069322594,0.0011560458,0.00015274645,0.9697987],"genre_scores_gemma":[0.008268342,0.001714331,0.00031941748,0.00035997047,0.0009205927,0.00009594948,0.0001991,0.0005156492,0.98760664],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99863976,0.000027509304,0.0002574213,0.00038981263,0.00042433242,0.00026118796],"domain_scores_gemma":[0.998905,0.000008648122,0.00018659329,0.00057253457,0.00011115009,0.00021608273],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006421997,0.00031819535,0.0006710063,0.00018459214,0.0000121310795,0.000004361856,0.00011012708,0.0002860463,0.038904928],"category_scores_gemma":[0.00001695067,0.00025500567,0.00015549442,0.00021997753,0.00015597057,0.000017196737,0.000045331693,0.00014420104,0.00011366902],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024394233,0.00018838838,0.005867542,0.00036053115,0.0016711787,0.00002333042,0.000054178796,4.511082e-8,0.000043409345,0.000005872952,0.9831314,0.008410175],"study_design_scores_gemma":[0.0026564393,0.00014991488,0.0041581644,0.0005629128,0.00077306945,0.000010808002,0.000028390605,0.000004664706,0.00062785996,0.000032472173,0.99078196,0.00021331753],"about_ca_topic_score_codex":0.0045226365,"about_ca_topic_score_gemma":0.0010064521,"teacher_disagreement_score":0.038791258,"about_ca_system_score_codex":0.00006455756,"about_ca_system_score_gemma":0.00095029443,"threshold_uncertainty_score":0.9999902},"labels":[],"label_agreement":null},{"id":"W2191471066","doi":"10.3233/blc-150021","title":"Bladder Cancer Patient Advocacy: A Global Perspective","year":2015,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Globe; Patient advocacy; Medicine; Public relations; Political science; Non profit; Perspective (graphical); Cancer; Nursing; Family medicine; MEDLINE; Public administration; Internal medicine","score_opus":0.07879779033624489,"score_gpt":0.4203128336327744,"score_spread":0.3415150432965295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2191471066","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015849555,0.9538047,0.000009675022,0.00059159216,0.0022153982,0.0034219455,0.0023519609,0.0002471209,0.03734179],"genre_scores_gemma":[0.00006729824,0.9865329,0.00013241787,0.0014714265,0.0024936567,0.004153236,0.00020122329,0.0002674257,0.004680398],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948395,0.00019890166,0.0009870119,0.0016095295,0.0012466913,0.0011183582],"domain_scores_gemma":[0.9964377,0.000046252153,0.000587891,0.0011220148,0.00091235153,0.0008937555],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00013201236,0.0014296451,0.0035876518,0.0002204702,0.00015801344,0.00008521334,0.0003906222,0.000777344,0.0044362186],"category_scores_gemma":[0.000053827483,0.0010696335,0.0012935189,0.0010317271,0.00024291418,0.00015325351,0.00023172647,0.0008246483,0.0005930749],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0001752837,0.00042676582,0.00011076532,0.0030639973,0.0051894262,0.00022443378,0.00080632855,0.0000024045703,1.5156957e-7,0.00012893352,0.10608076,0.88379073],"study_design_scores_gemma":[0.0022630747,0.0005362299,0.000058069083,0.010007362,0.011296312,0.00021597515,0.0005196459,0.0000029049672,0.0000028442785,0.00020339494,0.97389805,0.0009961157],"about_ca_topic_score_codex":0.009634802,"about_ca_topic_score_gemma":0.0009096638,"teacher_disagreement_score":0.8827946,"about_ca_system_score_codex":0.0081783645,"about_ca_system_score_gemma":0.013347744,"threshold_uncertainty_score":0.9998453},"labels":[],"label_agreement":null},{"id":"W2257398199","doi":"10.3233/blc-150033","title":"Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy","year":2016,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Proportional hazards model; Oncology; Internal medicine; Univariate analysis; GLUT1; Hypoxia (environmental); Cohort; Glucose transporter; Cancer; Multivariate analysis; Pathology","score_opus":0.01382848012899163,"score_gpt":0.2512026517575058,"score_spread":0.23737417162851415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2257398199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99251133,0.0026638287,0.00041814588,0.0002462834,0.0008639245,0.0013198842,0.0018407938,0.000032167274,0.000103646315],"genre_scores_gemma":[0.9935357,0.0015420086,0.00011033061,0.0005552135,0.0012253962,0.0013058383,0.00015389602,0.00011475936,0.001456875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973854,0.0000875045,0.0004269586,0.00095910835,0.00040212547,0.00073893816],"domain_scores_gemma":[0.9988257,0.00002798149,0.00015623086,0.00045475096,0.00024281115,0.00029249533],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011940752,0.0004592168,0.000450635,0.00010541496,0.00007816256,0.00003517509,0.00027853076,0.00034203273,0.0008166898],"category_scores_gemma":[0.000025369289,0.0003121568,0.0001678234,0.00016851448,0.0001611595,0.00003334743,0.000037601927,0.00013575947,0.000005510102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043363087,0.00095001515,0.6885957,0.000111128684,0.00094535237,0.000009160958,0.00064133736,0.000014871844,0.21603836,0.000009614743,0.0050216494,0.08332647],"study_design_scores_gemma":[0.0126740225,0.0006993738,0.76088774,0.00014773269,0.00023852644,0.00000438931,0.000048671598,0.000018235944,0.06511861,0.000011429036,0.15929994,0.0008513129],"about_ca_topic_score_codex":0.0006757686,"about_ca_topic_score_gemma":0.0068533975,"teacher_disagreement_score":0.1542783,"about_ca_system_score_codex":0.0001068285,"about_ca_system_score_gemma":0.00045010197,"threshold_uncertainty_score":0.99993306},"labels":[],"label_agreement":null},{"id":"W2258126254","doi":"10.3233/blc-150034","title":"Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)","year":2016,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Guideline; Nice; Medicine; Presentation (obstetrics); Bladder cancer; Family medicine; Cancer; Intensive care medicine; Pathology; Internal medicine; Computer science; Surgery","score_opus":0.16288173485036742,"score_gpt":0.47426121375546115,"score_spread":0.31137947890509377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258126254","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014274582,0.98281413,0.00003245703,0.00094916846,0.0023490088,0.0029819002,0.0019197487,0.00012154476,0.008689292],"genre_scores_gemma":[0.00046424472,0.97849476,0.00020987971,0.0016514681,0.0034219828,0.002239332,0.00020008946,0.00036929452,0.012948965],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99374276,0.00014758942,0.002296357,0.0015263389,0.0012355138,0.0010514439],"domain_scores_gemma":[0.9951325,0.00033616935,0.0014764019,0.0016028271,0.0009318288,0.00052028353],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00021653897,0.0015008581,0.005170206,0.00050691963,0.00017079967,0.000044795765,0.0006584622,0.0009127081,0.007869844],"category_scores_gemma":[0.00016279591,0.0009968597,0.0014855184,0.00067622436,0.00030519243,0.00015878292,0.00020577485,0.00080833514,0.0006684167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018555016,0.0005018235,0.00036770754,0.008778568,0.0035813178,0.00004047617,0.00028323027,0.0000066983534,0.000048781854,0.000022449536,0.18502708,0.80115634],"study_design_scores_gemma":[0.0031059517,0.00064108666,0.00024745398,0.057910543,0.005995269,0.000017381024,0.00007370354,0.000006487829,0.0007161859,0.00002845194,0.9303028,0.00095469045],"about_ca_topic_score_codex":0.002780407,"about_ca_topic_score_gemma":0.0012369467,"teacher_disagreement_score":0.80020165,"about_ca_system_score_codex":0.0010484777,"about_ca_system_score_gemma":0.0050107418,"threshold_uncertainty_score":0.99977404},"labels":[],"label_agreement":null},{"id":"W2263980547","doi":"10.3233/blc-150026","title":"Inhibiting Immune Checkpoints for the Treatment of Bladder Cancer","year":2016,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Blockade; Immune checkpoint; Immune system; Medicine; Cancer; Immunotherapy; Oncology; Cancer research; Immunology; Internal medicine; Receptor","score_opus":0.08522930557432609,"score_gpt":0.39982140468445465,"score_spread":0.31459209911012853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2263980547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020820202,0.98869795,0.00007164846,0.00069338153,0.0013292644,0.0054374654,0.0021300495,0.000072143645,0.0015472777],"genre_scores_gemma":[0.00008872667,0.97105587,0.00009659895,0.0001879607,0.0027215346,0.010700444,0.00010531284,0.00026394584,0.014779606],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99659705,0.000079966405,0.0012212826,0.00084738893,0.0004749946,0.00077929924],"domain_scores_gemma":[0.99721545,0.00048237128,0.0008507984,0.00095865555,0.0002915275,0.00020117762],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015918046,0.0009785456,0.0029940417,0.00018927656,0.00021284341,0.000031972708,0.00030096716,0.00043954817,0.003650176],"category_scores_gemma":[0.000035379904,0.00048164447,0.001934197,0.00034842594,0.00025229395,0.00007826151,0.000056478686,0.00021506826,0.00008984155],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001740292,0.00037160362,0.00003455483,0.005371262,0.0067451396,0.000010442547,0.00026537295,5.7097594e-7,0.00002521217,0.000025713038,0.00389073,0.9830854],"study_design_scores_gemma":[0.00411763,0.0006750645,0.00006022017,0.018935813,0.01123041,0.000030235085,0.000046061108,0.000003560869,0.000802615,0.000026648167,0.9635926,0.00047915746],"about_ca_topic_score_codex":0.0013881862,"about_ca_topic_score_gemma":0.00020729528,"teacher_disagreement_score":0.98260623,"about_ca_system_score_codex":0.0011268355,"about_ca_system_score_gemma":0.0021942973,"threshold_uncertainty_score":0.99976355},"labels":[],"label_agreement":null},{"id":"W2342783650","doi":"10.3233/blc-169007","title":"Collaborating to Move Research Forward: Proceedings of the 10th Annual Bladder Cancer Think Tank","year":2016,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Bladder cancer; Multidisciplinary approach; Variety (cybernetics); Multidisciplinary team; Medicine; Medical education; Public relations; Cancer; Psychology; Engineering ethics; Political science; Engineering; Computer science; Nursing; Artificial intelligence; Internal medicine","score_opus":0.0353898670531876,"score_gpt":0.3639863883548209,"score_spread":0.3285965213016333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342783650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92814934,0.0032797463,0.000030068335,0.035208073,0.0010891353,0.0035607433,0.0016789922,0.00013627007,0.026867608],"genre_scores_gemma":[0.96140105,0.00056556053,0.00036902164,0.002815935,0.0012393685,0.0010390095,0.000002420093,0.00011155053,0.03245612],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966492,0.000049965012,0.0004743617,0.000675259,0.0013144008,0.00083678495],"domain_scores_gemma":[0.99697316,0.00011657787,0.0001741003,0.00045264675,0.0019442802,0.00033923856],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000454968,0.0003342701,0.0005118619,0.00019889092,0.00027857182,0.000043696833,0.00040672475,0.00018940757,0.0015681293],"category_scores_gemma":[0.00025896172,0.0001801202,0.00016947578,0.0014087607,0.00029932574,0.00025835296,0.00024538106,0.00032955233,0.00006084829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022444904,0.0006164701,0.16464171,0.00043324506,0.0021538588,0.000020924093,0.017797621,0.000019355326,0.15370223,0.0018769822,0.5545889,0.10190422],"study_design_scores_gemma":[0.01147828,0.001590783,0.27279475,0.0033539184,0.00093720027,0.000036286612,0.008384221,0.000033437434,0.44976613,0.0014658214,0.24909613,0.001063049],"about_ca_topic_score_codex":0.0018619534,"about_ca_topic_score_gemma":0.0005423595,"teacher_disagreement_score":0.3054928,"about_ca_system_score_codex":0.0006683344,"about_ca_system_score_gemma":0.001490184,"threshold_uncertainty_score":0.9993446},"labels":[],"label_agreement":null},{"id":"W2343178457","doi":"10.3233/blc-150032","title":"Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy","year":2016,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"University of Toronto","keywords":"Medicine; Cystectomy; Bladder cancer; Lymph node; Dissection (medical); Urology; Chemotherapy; Randomized controlled trial; Internal medicine; Surgery; Gynecology; Cancer","score_opus":0.0074304128108973674,"score_gpt":0.2530944535279718,"score_spread":0.2456640407170744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343178457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939799,0.0031306583,0.000033828706,0.0011179696,0.0000823995,0.00074191927,0.00028736348,0.000037344158,0.0005886258],"genre_scores_gemma":[0.99561113,0.0026148865,0.000077023484,0.0005943116,0.000117837495,0.00027262667,0.000021180545,0.00006727059,0.00062371977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837404,0.00003577083,0.00032298765,0.0005547633,0.00033484393,0.00037758343],"domain_scores_gemma":[0.99922866,0.000052546013,0.00013828279,0.00021677623,0.00016171123,0.00020204851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048664853,0.00034181128,0.0005644117,0.00016387932,0.00006086457,0.0000142919025,0.000056092435,0.00015045526,0.00041850342],"category_scores_gemma":[0.00000892462,0.00020849146,0.000056733097,0.00025562482,0.0002473889,0.00015520297,0.000026748228,0.00010322862,0.0000024983551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00272703,0.00039465382,0.9464371,0.00009163094,0.0005516671,0.000021877659,0.0007774221,0.0000031574348,0.0054964717,0.000010151977,0.00011882411,0.043369994],"study_design_scores_gemma":[0.021823466,0.00056911237,0.957515,0.0010632485,0.0003366712,0.000029502418,0.000071834686,0.00004033469,0.018027667,0.000024119285,0.00021997455,0.00027905958],"about_ca_topic_score_codex":0.00510401,"about_ca_topic_score_gemma":0.0011250793,"teacher_disagreement_score":0.043090936,"about_ca_system_score_codex":0.00033767152,"about_ca_system_score_gemma":0.00019092103,"threshold_uncertainty_score":0.8502035},"labels":[],"label_agreement":null},{"id":"W2532785857","doi":"10.3233/blc-160071","title":"Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact?","year":2016,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Cystectomy; Medicine; Bladder cancer; Urology; Renal function; Stage (stratigraphy); Chemotherapy; Cohort; Logistic regression; Urothelial carcinoma; Internal medicine; Surgery; Oncology; Cancer","score_opus":0.011106744369064803,"score_gpt":0.30958864481717724,"score_spread":0.29848190044811246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532785857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99134004,0.0024048307,0.00030703263,0.0015482458,0.0004354248,0.00068997784,0.000056846446,0.00008956334,0.0031280327],"genre_scores_gemma":[0.9967315,0.00024075975,0.000022444912,0.0010141514,0.00047325544,0.00013498947,0.0000046092982,0.00006725612,0.001310998],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984306,0.00008660167,0.00026103313,0.00039079066,0.00047608875,0.0003548521],"domain_scores_gemma":[0.9991553,0.00012288295,0.00011326542,0.00038081285,0.000049127644,0.00017864416],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001819785,0.00030773782,0.0005531617,0.00010108175,0.00005861258,0.000010618334,0.00008642668,0.00014655363,0.0024914683],"category_scores_gemma":[0.000027958697,0.00015810119,0.00047045152,0.00018059462,0.00006892874,0.00008375007,0.000015685475,0.00013484093,0.000060050304],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022598723,0.00043409428,0.13342498,0.00021758256,0.005265604,0.00012122116,0.0010292983,0.00000608664,0.17830086,0.00003454662,0.017894346,0.6406727],"study_design_scores_gemma":[0.058218867,0.023168063,0.13883412,0.003679796,0.002094877,0.000058755144,0.000041429696,0.00005245951,0.7442337,0.00015868718,0.028775865,0.00068333244],"about_ca_topic_score_codex":0.00035036766,"about_ca_topic_score_gemma":0.000014593093,"teacher_disagreement_score":0.6399893,"about_ca_system_score_codex":0.00032378096,"about_ca_system_score_gemma":0.0002414107,"threshold_uncertainty_score":0.9984204},"labels":[],"label_agreement":null},{"id":"W2580444273","doi":"10.3233/blc-160081","title":"The Rationale for Post-Operative Radiation in Localized Bladder Cancer","year":2017,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Bladder cancer; Cancer; Medicine; Radiation therapy; Medical physics; General surgery; Radiology; Internal medicine","score_opus":0.1166406513632305,"score_gpt":0.45455093499995636,"score_spread":0.33791028363672587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580444273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009577249,0.9869263,0.000051302184,0.0021080482,0.0013930756,0.0065445853,0.0012971116,0.00004234813,0.0016276449],"genre_scores_gemma":[0.000029709301,0.9630736,0.000075749034,0.0009353749,0.0017783232,0.015958115,0.00056206726,0.00014697885,0.017440088],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99721223,0.000155912,0.00081407354,0.00076482305,0.00044741321,0.00060553727],"domain_scores_gemma":[0.9977516,0.0003526913,0.00055549556,0.00078386307,0.000382305,0.0001740569],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029018935,0.00066397275,0.0017601644,0.00017788704,0.00055172166,0.00017318153,0.0003660488,0.00042801673,0.00085115194],"category_scores_gemma":[0.00018130626,0.00041206984,0.0006751051,0.00020978427,0.00021231023,0.0001829692,0.000059054455,0.0004581265,0.000063067426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026423144,0.000102555045,0.00004889826,0.0019786635,0.0015999736,0.000011530755,0.00040050532,0.0000065492522,0.0000012963595,0.00014593215,0.018174913,0.97726494],"study_design_scores_gemma":[0.0036123157,0.00017764588,0.00013923491,0.004832345,0.002331548,0.000013748126,0.000074805204,0.00004644111,0.000015782036,0.0000685211,0.98825586,0.00043174956],"about_ca_topic_score_codex":0.0016603147,"about_ca_topic_score_gemma":0.004107318,"teacher_disagreement_score":0.9768332,"about_ca_system_score_codex":0.0010460645,"about_ca_system_score_gemma":0.0048632706,"threshold_uncertainty_score":0.9998331},"labels":[],"label_agreement":null},{"id":"W2581289368","doi":"10.3233/blc-160084","title":"Efficacy of Mycobacterium Phlei Cell Wall-Nucleic Acid Complex (MCNA) in BCG-Unresponsive Patients","year":2016,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Telesta Therapeutics (Canada); Campbell Scientific (Canada)","funders":"","keywords":"Medicine; Cystoscopy; Biopsy; Cytology; Internal medicine; BCG vaccine; Urology; Surgery; Urinary system; Vaccination; Pathology","score_opus":0.023480088925008715,"score_gpt":0.2858945950353526,"score_spread":0.2624145061103439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581289368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99268574,0.0005883939,0.00001650925,0.001108532,0.00035234122,0.0008187362,0.00023155892,0.00004763578,0.004150567],"genre_scores_gemma":[0.9962644,0.0002902748,0.00013639765,0.0010464046,0.00016836575,0.00011766977,0.0000334464,0.000061730265,0.0018813366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981657,0.000076498596,0.0004390639,0.00045233621,0.00040412383,0.0004622743],"domain_scores_gemma":[0.99887514,0.0000968405,0.0001731448,0.000456577,0.00020811026,0.0001901582],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007368882,0.00029294964,0.000529915,0.00018623353,0.00003916958,0.00000952733,0.0001574231,0.00012860668,0.0029341555],"category_scores_gemma":[0.00005051966,0.00020090517,0.000157943,0.0002719039,0.00013349413,0.000120722405,0.00006862702,0.00012202899,0.00015006124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073823687,0.0024861142,0.59628165,0.00025845866,0.0004577415,0.00006565225,0.0016834859,0.0000032522414,0.32103223,0.00003574565,0.014040001,0.056273304],"study_design_scores_gemma":[0.01807342,0.0006709878,0.89397794,0.0003564031,0.00017715846,0.0000038119226,0.000043170967,0.0000049589435,0.074570544,0.000032300166,0.011832221,0.0002570682],"about_ca_topic_score_codex":0.00045464616,"about_ca_topic_score_gemma":0.00011708232,"teacher_disagreement_score":0.2976963,"about_ca_system_score_codex":0.00032653467,"about_ca_system_score_gemma":0.00032088393,"threshold_uncertainty_score":0.9979773},"labels":[],"label_agreement":null},{"id":"W2606278562","doi":"10.3233/blc-160090","title":"Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer","year":2017,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Everolimus; Medicine; Clinical endpoint; Bladder cancer; Toxicity; Radiation therapy; Gemcitabine; Internal medicine; Urology; Oncology; Cohort; Clinical trial; Biopsy; Surgery; Cancer","score_opus":0.06506383417355531,"score_gpt":0.391303302315246,"score_spread":0.3262394681416907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606278562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99305046,0.00039830783,0.000014402396,0.0009383552,0.0006515984,0.0032338237,0.0002974472,0.000040701616,0.0013749128],"genre_scores_gemma":[0.9960256,0.0011754557,0.00008390972,0.000893424,0.000519828,0.00075251184,0.00004482196,0.00008560592,0.00041883482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708885,0.00014484672,0.00070538936,0.0007537601,0.00077151303,0.0005356432],"domain_scores_gemma":[0.9971989,0.00011522436,0.0007133266,0.0012287376,0.00045281244,0.00029099622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027462927,0.0004600414,0.0011623506,0.00011532199,0.00018082828,0.000046649362,0.00033429428,0.00022706266,0.00073623535],"category_scores_gemma":[0.000084953506,0.0002999659,0.00021716075,0.00018163171,0.00050962815,0.00027042162,0.000056969602,0.00038671793,0.0000065645927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32460138,0.008768354,0.6133035,0.000056027948,0.0016442311,0.00004277114,0.00041403025,0.000006946651,0.000050408868,0.00001589496,0.0009624293,0.050134048],"study_design_scores_gemma":[0.40840244,0.018709268,0.5700576,0.00027464525,0.00044006336,7.191703e-7,0.00003969917,0.000007764731,0.0010442755,0.000026104857,0.00072197855,0.00027549476],"about_ca_topic_score_codex":0.0038804302,"about_ca_topic_score_gemma":0.0032797484,"teacher_disagreement_score":0.083801046,"about_ca_system_score_codex":0.00021266847,"about_ca_system_score_gemma":0.0018533163,"threshold_uncertainty_score":0.9999452},"labels":[],"label_agreement":null},{"id":"W2606921055","doi":"10.3233/blc-160086","title":"Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy","year":2017,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"European Association of Urology","keywords":"Medicine; Urology; Cystectomy; Stromal cell; Prostate; Lamina propria; Lymphovascular invasion; Carcinoma in situ; Carcinoma; Prostatic urethra; Internal medicine; Oncology; Cancer; Bladder cancer; Pathology; Metastasis; Epithelium","score_opus":0.0703343992348148,"score_gpt":0.3408266273139776,"score_spread":0.27049222807916284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606921055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943745,0.00038190692,0.0000042735464,0.000748353,0.0005661772,0.001048823,0.0008968019,0.0000054377642,0.001973694],"genre_scores_gemma":[0.9981208,0.00004436457,0.00001682074,0.00016106004,0.00019291413,0.00012913956,0.0000018774699,0.00003112868,0.0013019019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998461,0.0000771758,0.0003600516,0.00023696535,0.000616306,0.00024847273],"domain_scores_gemma":[0.9981999,0.000029245908,0.00038717882,0.0011443102,0.00015890447,0.000080486774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012918303,0.0002120149,0.0004388744,0.000038954597,0.00010725341,0.0000100952675,0.00037926482,0.00008111273,0.00040121085],"category_scores_gemma":[0.000049778133,0.00010125233,0.00045244815,0.00008928346,0.000512641,0.0000479899,0.0001465552,0.00017411595,0.0000025581185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022025343,0.00039967406,0.98251384,0.00017575265,0.0006425876,0.0000050788835,0.0010350891,0.000013585138,0.009918981,0.000042286654,0.00072485284,0.0023257567],"study_design_scores_gemma":[0.004649842,0.0005615363,0.917801,0.0003583507,0.0002783899,0.0000030939889,0.000036765112,0.000009234641,0.075773254,0.00004968405,0.00039053636,0.000088320165],"about_ca_topic_score_codex":0.008307625,"about_ca_topic_score_gemma":0.0007145537,"teacher_disagreement_score":0.065854274,"about_ca_system_score_codex":0.00016505564,"about_ca_system_score_gemma":0.0008987382,"threshold_uncertainty_score":0.99829614},"labels":[],"label_agreement":null},{"id":"W2609244474","doi":"10.3233/blc-170105","title":"CDK4/6 Inhibitors in Cancer Therapy: A Novel Treatement Strategy for Bladder Cancer","year":2017,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Oncology; Disease; Internal medicine; Targeted therapy; Chemotherapy; Cisplatin; Blockade","score_opus":0.31958293087640177,"score_gpt":0.48469369882958757,"score_spread":0.1651107679531858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609244474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007522836,0.9814702,0.000019154668,0.0006882133,0.0022985407,0.0085683875,0.0037210353,0.0001235213,0.0030357086],"genre_scores_gemma":[0.00027432613,0.9451845,0.000081868144,0.0007348441,0.0037340405,0.032406855,0.00033160968,0.00046562098,0.016786305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942186,0.00009924945,0.0015619162,0.0018517982,0.00079157803,0.0014768838],"domain_scores_gemma":[0.99654394,0.00012270163,0.0010871935,0.0014279257,0.00032984323,0.0004884101],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0002923324,0.0017055598,0.0042849993,0.0005765781,0.00032397176,0.00019406946,0.0006473523,0.0009766499,0.002928508],"category_scores_gemma":[0.000030747782,0.001269827,0.001481368,0.00047489966,0.00024379775,0.00027118454,0.00012425092,0.0008547062,0.000045518937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003689923,0.000815859,0.0004885419,0.0071344823,0.0043630777,0.00004834301,0.00027863332,0.000020236312,0.000013802883,0.00002434426,0.019058835,0.9673849],"study_design_scores_gemma":[0.008878308,0.000542984,0.00038275486,0.022041008,0.0042316047,0.000022680979,0.000054472053,0.000016916925,0.00008893179,0.0000277488,0.96250355,0.0012090278],"about_ca_topic_score_codex":0.019714618,"about_ca_topic_score_gemma":0.009835042,"teacher_disagreement_score":0.96617585,"about_ca_system_score_codex":0.0024429192,"about_ca_system_score_gemma":0.0070936144,"threshold_uncertainty_score":0.99956906},"labels":[],"label_agreement":null},{"id":"W2732881054","doi":"10.3233/blc-170118","title":"Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer","year":2017,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Clinical trial; Bladder cancer; Oncology; Internal medicine; Cancer","score_opus":0.32443124169326165,"score_gpt":0.5705046334976933,"score_spread":0.24607339180443166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732881054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7018692,0.004630018,0.00064484077,0.25761458,0.006962745,0.020845056,0.00070029875,0.00017024466,0.0065630083],"genre_scores_gemma":[0.80277103,0.0027026357,0.002611833,0.14620131,0.0067061456,0.015829535,0.000044077948,0.00027963758,0.022853814],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917926,0.0023145818,0.0018907384,0.0018676615,0.0009626288,0.001171785],"domain_scores_gemma":[0.9934148,0.0011987495,0.00072881894,0.0031431147,0.0004849558,0.0010295322],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0060446025,0.0007830036,0.0020764123,0.00028415126,0.0007993753,0.0006033572,0.002179143,0.0003991333,0.0030764716],"category_scores_gemma":[0.0035314371,0.00054568955,0.00038893375,0.00048433398,0.00030729565,0.0006481978,0.0010678914,0.0008865307,0.0005210477],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025167996,0.0013441403,0.03298597,0.0000817237,0.001916336,0.0004406664,0.008758545,0.00029344615,0.010831231,0.00012450453,0.48624995,0.4318055],"study_design_scores_gemma":[0.0071232403,0.0021623315,0.19885181,0.001012763,0.00071077346,0.0000136151475,0.0005329625,0.000050283303,0.018905621,0.0002324468,0.76947534,0.00092883175],"about_ca_topic_score_codex":0.021318864,"about_ca_topic_score_gemma":0.04141029,"teacher_disagreement_score":0.43087664,"about_ca_system_score_codex":0.0009888118,"about_ca_system_score_gemma":0.002322188,"threshold_uncertainty_score":0.9996995},"labels":[],"label_agreement":null},{"id":"W2767198233","doi":"10.3233/blc-170120","title":"Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer","year":2017,"lang":"en","type":"erratum","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Germinal center; Bladder cancer; Pathology; Follicular dendritic cells; CD20; Immune system; Lymphatic system; Cystectomy; H&E stain; CD8; CD3; Cancer; Medicine; Immunohistochemistry; B cell; T cell; Antibody; Immunology; Internal medicine; Antigen-presenting cell","score_opus":0.021314949336668693,"score_gpt":0.3151798573109079,"score_spread":0.29386490797423925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767198233","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10071856,0.23017538,0.00008369793,0.021017764,0.12905996,0.018904993,0.03216504,0.001762653,0.46611196],"genre_scores_gemma":[0.08268669,0.018285176,0.00017727305,0.007033215,0.014863213,0.003126482,0.0010967089,0.00094685855,0.8717844],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940887,0.0001524099,0.00086099625,0.0017592121,0.0015501207,0.0015885497],"domain_scores_gemma":[0.9966095,0.000050797753,0.0009303512,0.0015182704,0.00035819315,0.0005328492],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00020308878,0.0015218947,0.0020827372,0.0004952488,0.00038191827,0.00025735862,0.00078304455,0.0012987686,0.0069081616],"category_scores_gemma":[0.00006456855,0.0011680033,0.0004686647,0.0003026602,0.0003993191,0.00032719807,0.00021039421,0.0020382209,0.00008133996],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017912284,0.00043111577,0.07843599,0.0008757117,0.004322048,0.0015688809,0.0010204894,0.000052890093,0.00040293767,0.000021867398,0.8986809,0.012395947],"study_design_scores_gemma":[0.015831837,0.0006193524,0.24199498,0.0037311523,0.0029360494,0.0001295451,0.00018544869,0.00006491246,0.0022932196,0.00018595379,0.7298714,0.0021561666],"about_ca_topic_score_codex":0.032959737,"about_ca_topic_score_gemma":0.030586502,"teacher_disagreement_score":0.40567243,"about_ca_system_score_codex":0.0021451665,"about_ca_system_score_gemma":0.0077351485,"threshold_uncertainty_score":0.99999774},"labels":[],"label_agreement":null},{"id":"W2784972860","doi":"10.3233/blc-170148","title":"Peri-Operative Chemotherapy for Bladder Cancer: A Survey of Providers to Determine Barriers and Enablers","year":2018,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Referral; Bladder cancer; Chemotherapy; Specialty; Family medicine; Logistic regression; Oncology; Internal medicine; Cancer","score_opus":0.039327710959015244,"score_gpt":0.3484307314601679,"score_spread":0.3091030205011527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784972860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850369,0.003225809,0.0006470136,0.0045562163,0.0006203207,0.003561535,0.0010973697,0.00007316635,0.0011816592],"genre_scores_gemma":[0.98617685,0.00074892555,0.0012976256,0.0066712354,0.00051518297,0.0013884839,0.000026581254,0.00010115474,0.0030739512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982307,0.000053673913,0.0003478751,0.0005987817,0.00027554654,0.0004934056],"domain_scores_gemma":[0.9984433,0.000076539276,0.00011376758,0.00033724596,0.00059671816,0.00043241403],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019279424,0.00034007963,0.0006023684,0.00013013526,0.000157409,0.000033893917,0.00011941047,0.00012549464,0.0017256084],"category_scores_gemma":[0.00011610539,0.00027723887,0.000099876954,0.00032992935,0.00032913132,0.0001328597,0.000036965248,0.00009802535,0.000006030715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022879006,0.0006846734,0.38308793,0.0010564869,0.00822826,0.000026452088,0.046141405,0.00009911563,0.08129149,0.00007529614,0.16322914,0.29320073],"study_design_scores_gemma":[0.036626033,0.011026931,0.40442452,0.0010511297,0.0017361385,0.00004152663,0.0031008672,0.0015983888,0.3934706,0.00011868417,0.14485547,0.0019496992],"about_ca_topic_score_codex":0.011904083,"about_ca_topic_score_gemma":0.00861639,"teacher_disagreement_score":0.31217912,"about_ca_system_score_codex":0.0002050261,"about_ca_system_score_gemma":0.0011003084,"threshold_uncertainty_score":0.999968},"labels":[],"label_agreement":null},{"id":"W2785240241","doi":"10.3233/blc-170140","title":"Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer","year":2018,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Liquid biopsy; Bladder cancer; Circulating tumor DNA; DNA; Biopsy; Medicine; Pathology; Cancer research; Oncology; Cancer; Internal medicine; Chemistry; Biochemistry","score_opus":0.07686118986522397,"score_gpt":0.3952291138831574,"score_spread":0.31836792401793346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785240241","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021371467,0.9902552,0.000015662148,0.000116981,0.00081675773,0.0017984003,0.0011860911,0.00008583061,0.0035879267],"genre_scores_gemma":[0.002503964,0.9917201,0.00013679544,0.00045756123,0.0012717517,0.0017330284,0.0003141268,0.00025338627,0.001609314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946788,0.0002140101,0.0018348375,0.0014236982,0.00090384344,0.00094482023],"domain_scores_gemma":[0.9967512,0.00015042593,0.0011372226,0.0012611077,0.00035756396,0.0003425111],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033480418,0.0010968762,0.005444027,0.0016351816,0.00009428322,0.000037365113,0.00044497824,0.0005659405,0.0070223035],"category_scores_gemma":[0.000076357595,0.0008759755,0.0021136815,0.003912797,0.00029327086,0.00012744372,0.00016285224,0.0006471092,0.00007949987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095543696,0.0018878945,0.0085026985,0.046358947,0.13391478,0.0009877668,0.002336117,0.000093399474,0.00018685448,0.000097101554,0.010681456,0.7939975],"study_design_scores_gemma":[0.0026804379,0.0005028803,0.0023586182,0.027410135,0.10946555,0.000082813815,0.00011211249,0.000109718334,0.00014805303,0.000014975355,0.85559803,0.0015166879],"about_ca_topic_score_codex":0.0058492,"about_ca_topic_score_gemma":0.0023507504,"teacher_disagreement_score":0.8449166,"about_ca_system_score_codex":0.0011538352,"about_ca_system_score_gemma":0.003023851,"threshold_uncertainty_score":0.9993691},"labels":[],"label_agreement":null},{"id":"W2785248624","doi":"10.3233/blc-170147","title":"Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis","year":2018,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Hazard ratio; Overweight; Observational study; Internal medicine; Body mass index; Meta-analysis; Randomized controlled trial; Obesity; Cancer; Oncology; Confidence interval","score_opus":0.08219347439400798,"score_gpt":0.37341704542907805,"score_spread":0.2912235710350701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785248624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000073766128,0.9880707,0.000009054968,0.0004811247,0.00019730876,0.009330792,0.0013890213,0.00014317429,0.000371396],"genre_scores_gemma":[0.00028873104,0.9799297,0.00004073628,0.0011999996,0.00019065234,0.011965896,0.00025643283,0.00023613925,0.005891716],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99402153,0.0005240441,0.002046337,0.0017413818,0.00085363095,0.0008130628],"domain_scores_gemma":[0.9962567,0.00019011315,0.0013499459,0.001230085,0.00036799334,0.0006051418],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00045437226,0.0017229419,0.014846495,0.00056777336,0.00021349074,0.0001442338,0.00032437342,0.00074997975,0.004915229],"category_scores_gemma":[0.000091609814,0.0009915408,0.0032674454,0.0016512163,0.00031986207,0.00018737146,0.0001664701,0.0007173211,0.00004526722],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016457028,0.00009411241,0.00044312066,0.5217303,0.4741145,0.000026290214,0.00010191258,7.9131475e-8,9.4551346e-8,0.0000052208165,0.0026614654,0.0008064385],"study_design_scores_gemma":[0.0005749388,0.00022039429,0.00011695989,0.06185635,0.85870624,0.00003856482,0.000026094067,0.0000045879565,0.0000013856562,0.0000119288825,0.077636495,0.000806046],"about_ca_topic_score_codex":0.0013583661,"about_ca_topic_score_gemma":0.00041233684,"teacher_disagreement_score":0.45987394,"about_ca_system_score_codex":0.00039986137,"about_ca_system_score_gemma":0.000902435,"threshold_uncertainty_score":0.99977916},"labels":[],"label_agreement":null},{"id":"W2801404059","doi":"10.3233/blc-170146","title":"Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention","year":2018,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Malignancy; Incidence (geometry); Population; Venous thromboembolism; Chemotherapy; Cancer; Disease; Intensive care medicine; Surgery; Internal medicine; Thrombosis","score_opus":0.02795026218785261,"score_gpt":0.33076070518830103,"score_spread":0.3028104430004484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801404059","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04137938,0.9531923,0.000008836239,0.000038002763,0.0006366458,0.0036574153,0.00022167673,0.00007063768,0.0007951183],"genre_scores_gemma":[0.001962707,0.99527895,0.000104381186,0.00016359355,0.0005093238,0.0011459357,0.00020053334,0.00015683047,0.00047771868],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99671376,0.00016499757,0.0007820151,0.0010422207,0.0006494335,0.0006475771],"domain_scores_gemma":[0.9981492,0.00007302857,0.0007335205,0.000636921,0.00016176849,0.00024553435],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022884109,0.0008177161,0.003046012,0.00045060224,0.00014359094,0.00006995324,0.00022482831,0.0004142527,0.0011390126],"category_scores_gemma":[0.000040795792,0.00054593524,0.00029976328,0.00059060345,0.00021470738,0.00021508348,0.00020204224,0.000585269,0.000033075798],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005610578,0.0009921028,0.13178602,0.011599711,0.0038987428,0.00001586892,0.0008155666,0.0000039499314,4.2141764e-8,0.00005832707,0.02493742,0.8258361],"study_design_scores_gemma":[0.0016021746,0.000494818,0.33625343,0.021959517,0.006517667,0.0000015947205,0.000051550738,0.0000024800079,9.4134555e-7,0.000049333783,0.6324258,0.00064069626],"about_ca_topic_score_codex":0.0043525156,"about_ca_topic_score_gemma":0.0032296914,"teacher_disagreement_score":0.82519543,"about_ca_system_score_codex":0.00049554615,"about_ca_system_score_gemma":0.0006777206,"threshold_uncertainty_score":0.9997741},"labels":[],"label_agreement":null},{"id":"W2802165589","doi":"10.3233/blc-189032","title":"New Horizons in Bladder Cancer Research: Report of the 15th Meeting of the International Bladder Cancer Network (IBCN) in Lisbon, Portugal, October 21–23, 2017","year":2018,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Cancer; Medicine; Internal medicine","score_opus":0.07536507639488435,"score_gpt":0.38340234043299337,"score_spread":0.30803726403810905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802165589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87483966,0.02066544,0.000035985406,0.029414702,0.009362138,0.0038095769,0.00042267755,0.000080721635,0.061369084],"genre_scores_gemma":[0.96459764,0.0034317472,0.00026665165,0.0017707365,0.0042619244,0.000618485,0.00002026988,0.00013320595,0.024899356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99452394,0.00027667327,0.0013371601,0.0009300519,0.0018593706,0.0010727822],"domain_scores_gemma":[0.9964792,0.00017786425,0.0007357845,0.0014013407,0.00095807057,0.00024770593],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011669579,0.00048648042,0.00082986424,0.00030309876,0.00023184807,0.000045147448,0.0010015783,0.00032736323,0.0037536398],"category_scores_gemma":[0.00032342813,0.00031829224,0.00035263805,0.0017828186,0.0007717609,0.00023317228,0.00055921584,0.0009891302,0.00001556241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007438699,0.00037129148,0.6249367,0.00008886356,0.0010826143,0.00009675179,0.0028206515,0.00056017545,0.0039718277,0.00018357477,0.35910326,0.006040446],"study_design_scores_gemma":[0.0070913676,0.000347116,0.7901183,0.004108805,0.00064609206,0.00011068474,0.0008900935,0.0002655278,0.026718965,0.0010248735,0.167986,0.00069218065],"about_ca_topic_score_codex":0.07824801,"about_ca_topic_score_gemma":0.11209564,"teacher_disagreement_score":0.19111726,"about_ca_system_score_codex":0.0008947124,"about_ca_system_score_gemma":0.0048710047,"threshold_uncertainty_score":0.9999269},"labels":[],"label_agreement":null},{"id":"W2802549022","doi":"10.3233/blc-170133","title":"The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study","year":2018,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Calgary","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Neutrophil to lymphocyte ratio; Bladder cancer; Proportional hazards model; Confidence interval; Chemotherapy; Multivariate analysis; Retrospective cohort study; Cancer; Gastroenterology; Lymphocyte; Oncology","score_opus":0.010819790376582641,"score_gpt":0.26331263171826613,"score_spread":0.2524928413416835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802549022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928375,0.0009946012,0.0000020209773,0.00057415577,0.00030886906,0.005114325,0.00006426573,0.000029898443,0.00007437958],"genre_scores_gemma":[0.99604386,0.00013787414,0.00006629507,0.00048007656,0.00031299368,0.0028731679,0.0000038282205,0.000049601666,0.00003232942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978106,0.000114011156,0.00043291698,0.0005177717,0.00065316696,0.00047151148],"domain_scores_gemma":[0.998662,0.000047100202,0.00021785399,0.00052409305,0.00043361558,0.00011535003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017321663,0.0003101238,0.00037238846,0.00016571078,0.00026286815,0.000026875985,0.0002904834,0.00008139351,0.00010377647],"category_scores_gemma":[0.00010790692,0.0001794926,0.00008539481,0.00079849013,0.00039536937,0.00013922717,0.00012683221,0.00020567024,0.000005354727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021567016,0.0008572678,0.98800296,0.00004454928,0.00029368282,0.000013988431,0.0044505526,0.00003808036,0.00093939924,0.000011970303,0.000029302371,0.0031615286],"study_design_scores_gemma":[0.011266947,0.0004145946,0.98334557,0.00059706933,0.000121301266,0.0000012823458,0.00047238515,0.00023270037,0.0032005967,0.0000063517045,0.00012538269,0.00021584168],"about_ca_topic_score_codex":0.0015359897,"about_ca_topic_score_gemma":0.0134109855,"teacher_disagreement_score":0.011874995,"about_ca_system_score_codex":0.0009845666,"about_ca_system_score_gemma":0.0007875541,"threshold_uncertainty_score":0.74836445},"labels":[],"label_agreement":null},{"id":"W2884031435","doi":"10.3233/blc-180175","title":"Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer","year":2018,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; National Cancer Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Agence Nationale de la Recherche; Bladder Cancer Canada","keywords":"Bladder cancer; Immunotherapy; Context (archaeology); Medicine; Cancer; Disease; Perspective (graphical); Clinical trial; Cancer immunotherapy; Tumor microenvironment; Immune system; Oncology; Immunology; Internal medicine; Biology; Computer science","score_opus":0.03307595279235583,"score_gpt":0.3637603148918905,"score_spread":0.33068436209953467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884031435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8652617,0.085777484,0.0009896315,0.029082954,0.0031406386,0.0037321728,0.00014287575,0.00023375513,0.011638814],"genre_scores_gemma":[0.9839919,0.0036231978,0.00095726416,0.0055194316,0.0013820523,0.001110242,0.000005370698,0.00007807946,0.0033324615],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980161,0.000039765713,0.00036695576,0.0006385365,0.00032440462,0.0006142215],"domain_scores_gemma":[0.99879366,0.000094971685,0.0001295333,0.000517948,0.00033373001,0.00013017531],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041924958,0.00029826042,0.0003804674,0.00011914781,0.000805919,0.00007485904,0.00028252456,0.00012703685,0.0021915385],"category_scores_gemma":[0.00004192683,0.00019595437,0.00013998999,0.0004547587,0.0018982742,0.000198771,0.00005853538,0.00023328308,0.0000440351],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028508047,0.00032621255,0.029675268,0.00015781882,0.0026574554,0.0000070652145,0.03163993,0.0000040205828,0.11689277,0.0003893633,0.012244043,0.80315524],"study_design_scores_gemma":[0.035485096,0.0060838535,0.25174487,0.0011579125,0.0028403983,0.00014093041,0.0059088184,0.001671026,0.13222086,0.004860411,0.555803,0.0020828121],"about_ca_topic_score_codex":0.002011012,"about_ca_topic_score_gemma":0.0009841638,"teacher_disagreement_score":0.8010724,"about_ca_system_score_codex":0.0001942933,"about_ca_system_score_gemma":0.0011031608,"threshold_uncertainty_score":0.9987206},"labels":[],"label_agreement":null},{"id":"W2896542733","doi":"10.3233/blc-180184","title":"Venous Thromboembolism and Peri-Operative Chemotherapy for Muscle-Invasive Bladder Cancer: A Population-based Study","year":2018,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Cancer Care Ontario","keywords":"Medicine; Cystectomy; Venous thromboembolism; Bladder cancer; Chemotherapy; Incidence (geometry); Perioperative; Cancer; Urology; Surgery; Internal medicine; Thrombosis","score_opus":0.0234294671760765,"score_gpt":0.3434250159803532,"score_spread":0.31999554880427666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896542733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881621,0.0016504291,0.00019866064,0.004257543,0.0006628073,0.0041546733,0.00010414642,0.00011997832,0.0006896608],"genre_scores_gemma":[0.9856275,0.00068235764,0.0005323526,0.0085358275,0.0015232532,0.0024977135,0.000039594983,0.000105263636,0.00045616637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796945,0.000052696312,0.00036721933,0.0007313011,0.0003617929,0.0005175645],"domain_scores_gemma":[0.9987285,0.00009832888,0.00015776159,0.0004403397,0.00037659766,0.00019845205],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016785433,0.0003812486,0.0008759194,0.00014647424,0.00040901557,0.00008160916,0.0001313748,0.00011824955,0.0016383086],"category_scores_gemma":[0.00004614366,0.0003265404,0.00013248587,0.0002305602,0.00013406997,0.00012552406,0.000049369984,0.00013593814,0.000014808142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021014998,0.022616971,0.41773927,0.0017263514,0.01506422,0.00010844697,0.10468973,0.0006781472,0.011018834,0.002106658,0.15213506,0.27001482],"study_design_scores_gemma":[0.007443438,0.0031388896,0.96554846,0.00027036076,0.0011702691,0.0000020715192,0.002855409,0.0006009169,0.0020295822,0.0001542244,0.016237747,0.0005486077],"about_ca_topic_score_codex":0.004711399,"about_ca_topic_score_gemma":0.008016289,"teacher_disagreement_score":0.54780924,"about_ca_system_score_codex":0.0002532132,"about_ca_system_score_gemma":0.00041263842,"threshold_uncertainty_score":0.99991864},"labels":[],"label_agreement":null},{"id":"W2898021123","doi":"10.3233/blc-189037","title":"A Festschrift in Honor of Edward M. Messing, MD, FACS","year":2018,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"National Cancer Institute","keywords":"Honor; Medicine; Gerontology; Computer science","score_opus":0.024279809841021176,"score_gpt":0.33363532590499817,"score_spread":0.309355516063977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898021123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89748836,0.007907114,0.00016006586,0.0014100487,0.00093919394,0.00082292676,0.0000831183,0.00009206285,0.09109712],"genre_scores_gemma":[0.9949338,0.00057384575,0.0005070743,0.0010605634,0.00054728554,0.000102588085,0.000006973516,0.0000363835,0.0022315255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988558,0.000026164631,0.00027619748,0.00028937016,0.0002518906,0.00030057383],"domain_scores_gemma":[0.999353,0.000017486536,0.00008533285,0.00030480686,0.00012614448,0.00011323495],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007366356,0.00017289568,0.00035984913,0.0001276135,0.000037215337,0.000009651557,0.00009004377,0.00010150161,0.0019141124],"category_scores_gemma":[0.000021833957,0.000142219,0.00008939426,0.00028809236,0.00017278765,0.00007882019,0.000033657063,0.00012569939,0.00007628611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020782512,0.0012375788,0.74721855,0.00041699348,0.00090207567,0.0001336197,0.0056630806,0.000008553855,0.026630942,0.00065315905,0.08234506,0.13271217],"study_design_scores_gemma":[0.014614355,0.0018277052,0.5337151,0.0013162221,0.0005726116,0.000058496546,0.0004480357,0.00010873229,0.17178062,0.00048385904,0.27442247,0.000651766],"about_ca_topic_score_codex":0.0019342733,"about_ca_topic_score_gemma":0.0012879717,"teacher_disagreement_score":0.21350339,"about_ca_system_score_codex":0.000090231966,"about_ca_system_score_gemma":0.00046130407,"threshold_uncertainty_score":0.9989983},"labels":[],"label_agreement":null},{"id":"W2913908440","doi":"10.1016/b978-0-12-809939-1.00032-1","title":"Microbiome","year":2017,"lang":"en","type":"book-chapter","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Computer science","score_opus":0.038567343996304626,"score_gpt":0.31177386915045674,"score_spread":0.2732065251541521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913908440","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043579486,0.01614544,0.0000062043728,0.0013554636,0.0011685822,0.0006872474,0.00056542555,0.00011213813,0.9799159],"genre_scores_gemma":[0.0021772936,0.00424137,0.00010674171,0.0017504802,0.0019218142,0.00009062007,0.00014687348,0.00019065748,0.98937416],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846244,0.000004359519,0.0002742604,0.0005938676,0.0003186223,0.0003464317],"domain_scores_gemma":[0.99835956,0.0000112610205,0.00024035454,0.0010216074,0.00013874841,0.0002284773],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000039585506,0.00050638575,0.00071970414,0.00013896763,0.00016010557,0.00005220998,0.00021431582,0.00047268986,0.015169506],"category_scores_gemma":[0.000005989434,0.00043189494,0.000375995,0.000009256581,0.00019673322,0.000060822884,0.00008170088,0.00040307117,0.0013658901],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084102736,0.00020352514,0.00085200055,0.00082714466,0.007088632,0.0012793879,0.00037434278,6.7118486e-7,0.0021083564,0.007846304,0.7870744,0.19150423],"study_design_scores_gemma":[0.001860144,0.00016635972,0.0006780207,0.00090668385,0.001191626,0.00009344774,0.0000021833637,6.1202155e-7,0.00066749897,0.0015677707,0.99243873,0.00042689324],"about_ca_topic_score_codex":0.00026023723,"about_ca_topic_score_gemma":0.00014688831,"teacher_disagreement_score":0.20536438,"about_ca_system_score_codex":0.000305096,"about_ca_system_score_gemma":0.0007469478,"threshold_uncertainty_score":0.99981326},"labels":[],"label_agreement":null},{"id":"W2950270989","doi":"10.3233/blc-190218","title":"Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer","year":2019,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Medicine; Oncology; Internal medicine; Bladder cancer; PD-L1; Meta-analysis; Immunotherapy; Blockade; Clinical trial; Disease; Cancer","score_opus":0.03949301475115467,"score_gpt":0.3752436445870284,"score_spread":0.3357506298358737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950270989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005365829,0.98425615,0.00002081212,0.0008751948,0.0012721793,0.005618832,0.00084412505,0.00009214389,0.001654764],"genre_scores_gemma":[0.0025592817,0.9875316,0.00034369057,0.00063065055,0.00030552802,0.0036460776,0.00012860162,0.00041503666,0.004439519],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99368757,0.00043589465,0.0020438076,0.0016228934,0.0010037774,0.0012060743],"domain_scores_gemma":[0.9963136,0.00022208584,0.0008290123,0.0018208775,0.00030387347,0.0005105694],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005597577,0.0013851908,0.004583901,0.0011084182,0.000063285945,0.00003424447,0.0006316558,0.00079494866,0.002305022],"category_scores_gemma":[0.00017408277,0.0011653852,0.0014664725,0.0018467988,0.00018581167,0.00012853832,0.0002841243,0.00085243915,0.00022412666],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009157984,0.00085373264,0.00033953149,0.02173097,0.0085933,0.00049799506,0.0008490017,0.00016108954,0.008346513,0.000011564823,0.0019459861,0.9475123],"study_design_scores_gemma":[0.006531715,0.00080774794,0.0016800849,0.03237378,0.0056220456,0.00006427098,0.00012636223,0.00000911114,0.0060505625,0.000014112746,0.9453644,0.0013557975],"about_ca_topic_score_codex":0.0029371525,"about_ca_topic_score_gemma":0.00033386823,"teacher_disagreement_score":0.94615656,"about_ca_system_score_codex":0.001804625,"about_ca_system_score_gemma":0.0046397415,"threshold_uncertainty_score":0.99988985},"labels":[],"label_agreement":null},{"id":"W2969722359","doi":"10.3233/blc-190228","title":"Investigating the STING Pathway to Explain Mechanisms of BCG Failures in Non-Muscle Invasive Bladder Cancer: Prognostic and Therapeutic Implications","year":2019,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Sting; Bladder cancer; Medicine; Cancer; Oncology; Cancer research; Internal medicine; Engineering","score_opus":0.01753233826615099,"score_gpt":0.2573248348540697,"score_spread":0.2397924965879187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969722359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98409396,0.009743084,0.00022073142,0.003014623,0.0006871913,0.0015726464,0.00008341476,0.000038635128,0.00054569705],"genre_scores_gemma":[0.9959351,0.00024564515,0.00024864957,0.001762373,0.000039343024,0.0011155141,0.000012546598,0.00004354563,0.00059732207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983747,0.00017233969,0.00043163347,0.00046401675,0.00007068083,0.00048662472],"domain_scores_gemma":[0.9985543,0.0005838689,0.00024105675,0.00046177834,0.00012633718,0.00003269498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003133407,0.00025159045,0.00034816685,0.00012267016,0.00017530505,0.000024575053,0.0003788356,0.00018572804,0.00064860063],"category_scores_gemma":[0.00011970432,0.00019609985,0.00005731038,0.00038151242,0.00022328374,0.000086699,0.00021103368,0.00037707668,0.000058017016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001827561,0.000039289243,0.026385503,0.00008128097,0.0002036636,5.082578e-7,0.005736802,0.0005527579,0.94553113,0.0016560722,0.00049231364,0.019302402],"study_design_scores_gemma":[0.0023378488,0.00032117686,0.2882311,0.0010124608,0.0001676514,0.000016196453,0.0071833446,0.000091318376,0.6874661,0.0045243325,0.007874943,0.0007735404],"about_ca_topic_score_codex":0.0025084533,"about_ca_topic_score_gemma":0.0027812046,"teacher_disagreement_score":0.2618456,"about_ca_system_score_codex":0.000113870134,"about_ca_system_score_gemma":0.00040024475,"threshold_uncertainty_score":0.799672},"labels":[],"label_agreement":null},{"id":"W2996535743","doi":"10.3233/blc-190252","title":"Docetaxel with or without Ramucirumab after Platinum-Based Chemotherapy and Checkpoint Inhibitors in Advanced Urothelial Carcinoma: A Pre-Specified Subgroup Analysis from the Phase 3 RANGE Trial","year":2019,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Ipsen; Incyte; Astellas Pharma; Clovis Oncology; Exelixis; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Docetaxel; Ramucirumab; Medicine; Internal medicine; Placebo; Hazard ratio; Subgroup analysis; Oncology; Chemotherapy; Adverse effect; Progression-free survival; Urology; Confidence interval; Pathology","score_opus":0.016504199327409465,"score_gpt":0.29406316570677776,"score_spread":0.2775589663793683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996535743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919558,0.0020561405,0.00014523402,0.0010764755,0.0002565809,0.0038522054,0.0002929389,0.00006019253,0.00030443838],"genre_scores_gemma":[0.9946009,0.0001377019,0.00039075443,0.001808558,0.0006429517,0.0013896872,0.000060077586,0.0000909532,0.00087845296],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974665,0.00010535161,0.0005354163,0.00084546924,0.0005605919,0.0004866406],"domain_scores_gemma":[0.9986643,0.00013761291,0.00021131786,0.00071211735,0.000087080334,0.0001875607],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017114832,0.0004919035,0.0010084707,0.00019740852,0.00007054563,0.00006819987,0.0001490806,0.00016625776,0.0028776547],"category_scores_gemma":[0.000016958082,0.00027943458,0.0002500255,0.0007704877,0.00015322705,0.0001547736,0.000030326326,0.00033898582,0.000013889782],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5149277,0.0008582533,0.46904188,0.00005526405,0.0014901531,0.0000720063,0.0031705683,0.000058778503,0.0011713883,0.0000016170791,0.00014335969,0.00900907],"study_design_scores_gemma":[0.5322753,0.0037479748,0.4471123,0.0003215265,0.002536817,0.000008034291,0.0005104314,0.0015678804,0.007724505,0.000018022507,0.0035109827,0.0006662333],"about_ca_topic_score_codex":0.0042067715,"about_ca_topic_score_gemma":0.0066563743,"teacher_disagreement_score":0.02192958,"about_ca_system_score_codex":0.00025815342,"about_ca_system_score_gemma":0.00057573174,"threshold_uncertainty_score":0.9999658},"labels":[],"label_agreement":null},{"id":"W3008603272","doi":"10.3233/blc-190254","title":"Statins are Associated with Reduced Overall and Cancer-Specific Mortality in Patients Undergoing Radical Cystectomy for Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Ministère de la Santé et des Services sociaux","keywords":"Medicine; Cystectomy; Bladder cancer; Hazard ratio; Statin; Proportional hazards model; Internal medicine; Confidence interval; Cancer; Comorbidity; Cohort; Surgery","score_opus":0.023399208467932805,"score_gpt":0.26997773912077444,"score_spread":0.24657853065284163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008603272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867389,0.008826454,0.00016304944,0.00084443187,0.0015144212,0.0007980182,0.0009922509,0.000027631211,0.000094845505],"genre_scores_gemma":[0.98631126,0.006081752,0.000109726425,0.002061399,0.0041595506,0.00073831563,0.00021222641,0.000080373626,0.0002453856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980572,0.00007390741,0.0003403793,0.0007526332,0.00027230577,0.0005035913],"domain_scores_gemma":[0.99909484,0.000031096504,0.00024093503,0.00022318671,0.00018086389,0.00022909291],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0000951665,0.00031558864,0.00042847384,0.000040756135,0.000105710445,0.000047145117,0.00015445393,0.00020112314,0.00010686696],"category_scores_gemma":[0.00008027617,0.00029079732,0.00008866129,0.00017747871,0.0001316649,0.000017862942,0.0000731972,0.00018182087,5.998313e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029029343,0.00047152812,0.7338248,0.0004191193,0.0020289312,0.0000019879683,0.002112052,0.0020119466,0.060336642,0.000095398354,0.18204567,0.013748979],"study_design_scores_gemma":[0.014458971,0.0004972218,0.6898789,0.0002986969,0.0002354797,7.0081e-7,0.00028396407,0.00024134667,0.0081945965,0.000034735793,0.2849449,0.0009305305],"about_ca_topic_score_codex":0.0009932781,"about_ca_topic_score_gemma":0.011509101,"teacher_disagreement_score":0.10289922,"about_ca_system_score_codex":0.0001484287,"about_ca_system_score_gemma":0.0005610152,"threshold_uncertainty_score":0.9999544},"labels":[],"label_agreement":null},{"id":"W3008920943","doi":"10.3233/blc-190262","title":"Does 5-alpha Reductase Inhibitor Use Improve The Efficacy of Intravesical Bacille Calmette-Guérin (BCG) for Non-muscle Invasive Bladder Cancer?","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Bladder cancer; Medicine; Concomitant; Proportional hazards model; Internal medicine; Urology; Cancer; Univariate analysis; Multivariate analysis; Oncology","score_opus":0.03247378600753348,"score_gpt":0.3002018281045135,"score_spread":0.26772804209698003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008920943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9578053,0.001722711,0.00026089785,0.0299135,0.0019775736,0.0047970572,0.0028476417,0.00013051328,0.0005448055],"genre_scores_gemma":[0.9851823,0.0008475084,0.00049747655,0.0073056766,0.003556866,0.0014251454,0.00008192177,0.00013509455,0.00096803455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99713284,0.00007278625,0.0006808269,0.0008557479,0.00056198554,0.0006958004],"domain_scores_gemma":[0.9977023,0.00047025498,0.00028315381,0.0006645627,0.000380866,0.0004988446],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012549946,0.0005199928,0.000824839,0.00007918192,0.00020369171,0.00006424363,0.0003258394,0.00022239004,0.0010209221],"category_scores_gemma":[0.0003890155,0.00029013513,0.00042853816,0.00043296372,0.00036816133,0.00023599193,0.00014125112,0.00042478714,0.000025995645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011602038,0.0025055546,0.0155270435,0.0020265095,0.007198342,0.00018451626,0.019384554,0.00020292679,0.55988,0.00039217353,0.23665182,0.14444453],"study_design_scores_gemma":[0.027419027,0.0035965405,0.050821353,0.00069995207,0.0035004783,0.000012845992,0.0022056294,0.0007078798,0.8235049,0.00018851279,0.086094804,0.0012480243],"about_ca_topic_score_codex":0.002557335,"about_ca_topic_score_gemma":0.00056611665,"teacher_disagreement_score":0.26362497,"about_ca_system_score_codex":0.00024914963,"about_ca_system_score_gemma":0.0013328706,"threshold_uncertainty_score":0.99995506},"labels":[],"label_agreement":null},{"id":"W3036728523","doi":"10.3233/blc-200291","title":"Current Management of Localized Muscle-Invasive Bladder Cancer: A Consensus Guideline from the Genitourinary Medical Oncologists of Canada","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; McMaster University; University of Manitoba; Juravinski Cancer Centre; London Health Sciences Centre; Université de Montréal; Centre Hospitalier de l’Université de Montréal; University of British Columbia; Saint John Regional Hospital; Queen Elizabeth II Health Sciences Centre; University of Alberta; McGill University Health Centre; University of Ottawa; CancerCare Manitoba; University Health Network; Ottawa Hospital; University of Calgary; Princess Margaret Cancer Centre; Dalhousie University; Western University; University of Toronto","funders":"","keywords":"Guideline; Medicine; Bladder cancer; MEDLINE; Standardization; Intensive care medicine; Genitourinary system; Multidisciplinary approach; Evidence-based medicine; Clinical trial; Medical physics; Cancer; Alternative medicine; Pathology; Internal medicine","score_opus":0.03972413607044959,"score_gpt":0.32816742248379516,"score_spread":0.28844328641334555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036728523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6710926,0.16102234,0.00054016366,0.14901313,0.0036330812,0.0042925267,0.004898161,0.00016172242,0.0053462274],"genre_scores_gemma":[0.97361463,0.0131989475,0.0006986667,0.01037357,0.0013085542,0.0003927238,0.000106398096,0.000070824964,0.00023570718],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966413,0.00012439485,0.0009373375,0.0005451833,0.0012989849,0.00045280918],"domain_scores_gemma":[0.99807835,0.00023245324,0.0003721538,0.00049216836,0.00035262422,0.0004722662],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014730432,0.0003588371,0.00079091,0.000032255983,0.00008422023,0.0000068593504,0.00038049542,0.0001297643,0.005041604],"category_scores_gemma":[0.00010853145,0.00024593613,0.00020993981,0.00035042636,0.00032708718,0.00002395362,0.00020621675,0.00033388066,0.0000052342493],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026901218,0.00073501427,0.025941812,0.0009256635,0.0061656046,0.0011968011,0.0015169625,0.00036105243,0.00089777017,0.0001016158,0.835596,0.123871565],"study_design_scores_gemma":[0.033476815,0.0016772194,0.13094817,0.003857073,0.006841047,0.000049078826,0.0049728896,0.002101526,0.01774136,0.00028781017,0.79678875,0.0012582428],"about_ca_topic_score_codex":0.40691555,"about_ca_topic_score_gemma":0.23020358,"teacher_disagreement_score":0.30252197,"about_ca_system_score_codex":0.00039645788,"about_ca_system_score_gemma":0.0064609908,"threshold_uncertainty_score":0.9999993},"labels":[],"label_agreement":null},{"id":"W3087173170","doi":"10.3233/blc-200304","title":"Review: Brain Metastases in Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; Oncology; Internal medicine; Bladder cancer; Chemotherapy; Cancer; Immune checkpoint; Immunotherapy","score_opus":0.05421260220501826,"score_gpt":0.35685702628000804,"score_spread":0.30264442407498976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087173170","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02431531,0.6712426,0.00011628317,0.2988651,0.00034500964,0.0019422341,0.00055465946,0.00014700579,0.0024717897],"genre_scores_gemma":[0.22352421,0.21148284,0.0021592285,0.5551384,0.001712078,0.0022548216,0.0002769765,0.00019670544,0.0032547575],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982045,0.000113451635,0.0004100311,0.00052681606,0.00032278008,0.00042238936],"domain_scores_gemma":[0.99908257,0.00008021757,0.00010640937,0.00032444703,0.000078879086,0.000327482],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019466062,0.00029275808,0.0006655344,0.00006641174,0.000042882817,0.00001620293,0.00011182462,0.000064062566,0.009797611],"category_scores_gemma":[0.00015216372,0.00022584299,0.00020882626,0.0005373587,0.00006540816,0.00009329864,0.000059712187,0.00025121897,0.00013617716],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018655232,0.00027082302,0.008736073,0.0013344361,0.0008959734,0.0003324511,0.00037751987,0.000062891806,0.00059240876,0.00012701526,0.91898936,0.068094485],"study_design_scores_gemma":[0.0036741204,0.00026350163,0.009149493,0.0019352025,0.000939639,0.000022117865,0.000120611985,0.00013840786,0.001464246,0.000031741656,0.9819176,0.00034331664],"about_ca_topic_score_codex":0.001361695,"about_ca_topic_score_gemma":0.00070337736,"teacher_disagreement_score":0.45975977,"about_ca_system_score_codex":0.00014518759,"about_ca_system_score_gemma":0.0003579247,"threshold_uncertainty_score":0.9911076},"labels":[],"label_agreement":null},{"id":"W3088838079","doi":"10.3233/blc-200315","title":"Optimizing Sequence of PD-L1 Immune-Checkpoint Inhibitors and Radiation Therapy in Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Immunotherapy; Bladder cancer; Radiation therapy; Adjuvant; Immune system; Oncology; Combination therapy; Cancer; Immune checkpoint; Adjuvant therapy; Neoadjuvant therapy; Urology; Internal medicine; Cancer research; Immunology; Breast cancer","score_opus":0.041541753087410156,"score_gpt":0.31149986409305747,"score_spread":0.2699581110056473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088838079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9393926,0.0503922,0.000051830255,0.0074246796,0.00034418047,0.0010076122,0.00011296247,0.000069520655,0.0012043847],"genre_scores_gemma":[0.97736424,0.019094845,0.0003505953,0.0022752376,0.0004272519,0.00026302395,0.000018971288,0.000055213994,0.00015060986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830353,0.000050394992,0.00052353315,0.00046492982,0.0003209026,0.00033673606],"domain_scores_gemma":[0.9992612,0.000034335302,0.00018897034,0.00021927063,0.00010048437,0.00019573791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103699305,0.0002792723,0.00051821966,0.00011132128,0.000051290594,0.000020471436,0.00009337203,0.00013516807,0.00078727084],"category_scores_gemma":[0.000029676048,0.00024084034,0.00012373479,0.00040911723,0.00012742326,0.00018629342,0.00004398282,0.0002496911,0.000006408368],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036450871,0.0005304948,0.25000477,0.0006029389,0.0016435937,0.000118979886,0.029998157,0.0012440262,0.4234552,0.00008085128,0.003037331,0.28563857],"study_design_scores_gemma":[0.026694963,0.0022145894,0.32392302,0.0012843404,0.0006187002,0.000033426117,0.002074468,0.0032651145,0.6161041,0.00018515314,0.02235081,0.0012513141],"about_ca_topic_score_codex":0.0044520977,"about_ca_topic_score_gemma":0.00019379437,"teacher_disagreement_score":0.28438726,"about_ca_system_score_codex":0.000203015,"about_ca_system_score_gemma":0.0004670227,"threshold_uncertainty_score":0.9821184},"labels":[],"label_agreement":null},{"id":"W3108500360","doi":"10.3233/blc-200306","title":"Tumor Subtyping: Making Sense of Heterogeneity with a Goal Toward Treatment","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Subtyping; Bladder cancer; Oncology; Medicine; Cancer; Internal medicine; Biology","score_opus":0.06357876085516496,"score_gpt":0.3230142290459608,"score_spread":0.2594354681907958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108500360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898042,0.0026800241,0.00026413926,0.002987241,0.00010761952,0.000763503,0.00012906494,0.000101004465,0.0031632227],"genre_scores_gemma":[0.9959386,0.00013392273,0.00064552284,0.0026363307,0.00032888664,0.00012277898,0.00001022576,0.000046688998,0.00013701599],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988244,0.000026939444,0.00022465143,0.00037617385,0.00026611108,0.0002817302],"domain_scores_gemma":[0.99936503,0.000015484058,0.00010640624,0.00022855424,0.000084153784,0.0002003912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000023046618,0.00024709772,0.00045901455,0.00003864151,0.0000412392,0.000011399119,0.000049365764,0.00004628789,0.00044199554],"category_scores_gemma":[0.000008447859,0.00017105196,0.00013999296,0.00019192116,0.0000770745,0.00005134593,0.00002446278,0.000083808205,0.000020854382],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024268936,0.0023569262,0.81232977,0.0017128955,0.00942959,0.003157754,0.018677073,0.00047597967,0.043222647,0.00023446113,0.005414397,0.07871955],"study_design_scores_gemma":[0.037893783,0.016292682,0.32341295,0.0013199105,0.004828917,0.000759767,0.0016481355,0.0011830273,0.54378206,0.000047934514,0.06736833,0.0014625079],"about_ca_topic_score_codex":0.0004296742,"about_ca_topic_score_gemma":0.00014011413,"teacher_disagreement_score":0.5005594,"about_ca_system_score_codex":0.00018181794,"about_ca_system_score_gemma":0.00041485156,"threshold_uncertainty_score":0.6975296},"labels":[],"label_agreement":null},{"id":"W3119352309","doi":"10.3233/blc-200404","title":"Revisiting an Old Conundrum: A Systematic Review and Meta-Analysis of Intravesical Therapy for Treatment of Urothelial Carcinoma of the Prostate","year":2021,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Meta-analysis; Prostate; Cochrane Library; Urology; Prostate cancer; Oncology; Systematic review; Carcinoma; Internal medicine; MEDLINE; Cancer","score_opus":0.12519937408883575,"score_gpt":0.39779407978007686,"score_spread":0.2725947056912411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119352309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011891247,0.98733455,0.0000064582055,0.00017893725,0.000040428204,0.009792839,0.0024829379,0.000006714078,0.00003820015],"genre_scores_gemma":[0.00057698356,0.9945868,0.00010345641,0.0002637358,0.000075532844,0.0034568787,0.00011678144,0.00006728752,0.00075252895],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9966439,0.00047889593,0.0017006691,0.0005461309,0.00039020373,0.00024021712],"domain_scores_gemma":[0.99664235,0.00025621694,0.001551097,0.0010509923,0.0003912022,0.0001081248],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031435848,0.0005563462,0.012355136,0.00016649997,0.000043520326,0.000011635717,0.00017829525,0.00015619793,0.00029493787],"category_scores_gemma":[0.000061547966,0.00026825245,0.0040713097,0.0007237741,0.00015049918,0.00003673894,0.000032546897,0.000082987666,2.481053e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050288116,0.00030828896,0.000051009334,0.68947285,0.28303793,0.0000041564335,0.00039524582,4.1668184e-7,0.0000054357133,0.00006589174,0.000024603545,0.026583843],"study_design_scores_gemma":[0.0011204904,0.0006669979,0.000038217895,0.045504518,0.94421387,0.000020985244,0.000041203068,0.000004689131,0.00015936192,0.0000038188564,0.008026221,0.000199616],"about_ca_topic_score_codex":0.00041993405,"about_ca_topic_score_gemma":0.000033332162,"teacher_disagreement_score":0.66117597,"about_ca_system_score_codex":0.00013992307,"about_ca_system_score_gemma":0.0009192044,"threshold_uncertainty_score":0.999977},"labels":[],"label_agreement":null},{"id":"W3126958718","doi":"10.3233/blc-200391","title":"Benefit of Adjuvant Chemotherapy After Radical Cystectomy for Treatment of Urothelial Carcinoma of the Bladder in the Elderly –An International Multicenter Study","year":2021,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Association of Urology","keywords":"Cystectomy; Urothelial carcinoma; Adjuvant chemotherapy; Medicine; Urology; Multicenter study; Chemotherapy; Adjuvant; Oncology; Internal medicine; Bladder cancer; Cancer; Randomized controlled trial","score_opus":0.024553411180815967,"score_gpt":0.32220724958652663,"score_spread":0.2976538384057107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126958718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994384,0.0013487323,0.000022907718,0.0011269515,0.00036458945,0.0020599244,0.00036985506,0.0000060061593,0.000317033],"genre_scores_gemma":[0.9976957,0.00015796961,0.0001680942,0.00039994545,0.0002638196,0.0008488702,0.000016772266,0.000035233017,0.00041361933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983364,0.000094422714,0.0005215921,0.00034066904,0.00048535375,0.00022160921],"domain_scores_gemma":[0.99884284,0.00008066913,0.00017819615,0.00059370423,0.00025022405,0.000054368855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010536845,0.00022571444,0.0005182055,0.000073054885,0.00003034683,0.000009479063,0.00023336554,0.0000801647,0.0006434672],"category_scores_gemma":[0.000016843424,0.00012583866,0.00029844345,0.00019115269,0.0001342168,0.000065587716,0.00002792076,0.000071494615,7.5142697e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005404439,0.00950353,0.9217265,0.00012711663,0.0017262358,0.000046185643,0.019043507,0.000031139054,0.006472867,0.00005200832,0.00012943981,0.035737015],"study_design_scores_gemma":[0.026203042,0.0035362162,0.9028532,0.00014735432,0.0006536389,0.000014996788,0.0024737786,0.00012564326,0.06055485,0.000046509565,0.0032444268,0.0001463596],"about_ca_topic_score_codex":0.0013887705,"about_ca_topic_score_gemma":0.0017139215,"teacher_disagreement_score":0.054081984,"about_ca_system_score_codex":0.00013956499,"about_ca_system_score_gemma":0.00037179363,"threshold_uncertainty_score":0.70455146},"labels":[],"label_agreement":null},{"id":"W3135800657","doi":"10.3233/blc-201510","title":"A Systematic Review of Outcome Reporting, Definition and Measurement Heterogeneity in Non-Muscle Invasive Bladder Cancer Effectiveness Trials of Adjuvant, Prophylactic Treatment After Transurethral Resection","year":2021,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bladder cancer; Resection; Adjuvant; Cancer; Randomized controlled trial; Urology; Oncology; Surgery; Internal medicine","score_opus":0.22093817884737793,"score_gpt":0.4348002948606458,"score_spread":0.21386211601326788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135800657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003933898,0.9823052,0.000017560133,0.000039004753,0.00040802243,0.012690645,0.00051606266,0.000019133986,0.000070446586],"genre_scores_gemma":[0.03543169,0.94688475,0.000043469267,0.000079971476,0.00014117146,0.017186437,0.00009318397,0.0001104103,0.00002893609],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9895613,0.0021698726,0.0058225924,0.0009856502,0.0010337417,0.00042681894],"domain_scores_gemma":[0.99241775,0.00046591504,0.0053906157,0.00080551056,0.00074378395,0.00017641991],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00375003,0.0008844812,0.011021166,0.0003614602,0.00004729374,0.000020640451,0.000107680564,0.00041494332,0.00024131003],"category_scores_gemma":[0.0018618272,0.0005956112,0.0017895454,0.0006547205,0.00011523443,0.000110819616,0.000042752585,0.00035203973,0.0000021264066],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033898276,0.0005822163,0.002041514,0.95176166,0.004874121,0.00013795508,0.00022752235,8.671622e-7,0.000066558576,0.0000011073574,0.000011623015,0.0399559],"study_design_scores_gemma":[0.0036574975,0.0010694598,0.004492631,0.94937265,0.038966507,0.00010678183,0.0000375224,6.9555904e-7,0.001229381,0.000007597903,0.0005702512,0.0004890509],"about_ca_topic_score_codex":0.0026420716,"about_ca_topic_score_gemma":0.0028722105,"teacher_disagreement_score":0.039466847,"about_ca_system_score_codex":0.0018781993,"about_ca_system_score_gemma":0.0024053706,"threshold_uncertainty_score":0.9996495},"labels":[],"label_agreement":null},{"id":"W3177003203","doi":"10.3233/blc-201526","title":"Impact of Intestinal Urinary Diversion on the Risk of Fracture and Loss of Bone Mass: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Urinary Tract Infections Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Urinary diversion; Medicine; Urinary system; Internal medicine; Cancer","score_opus":0.034779778754342836,"score_gpt":0.35125999078713294,"score_spread":0.3164802120327901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177003203","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026924905,0.9965286,0.000020437465,0.00011965217,0.000049717306,0.002574376,0.00009511405,0.0000091453385,0.00033369433],"genre_scores_gemma":[0.0012539305,0.99809813,0.000046339057,0.00007942987,0.00004462504,0.0001950029,0.000026561318,0.000029601908,0.00022640226],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99793327,0.00038557136,0.0009096721,0.00025721765,0.00037829363,0.00013594842],"domain_scores_gemma":[0.99679583,0.00050168426,0.0016709559,0.00076049776,0.00021397482,0.000057079942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005165568,0.0003246508,0.00292949,0.00018430922,0.00003348309,0.0000042442884,0.00012333988,0.00011334288,0.00068915176],"category_scores_gemma":[0.00044640823,0.00016796566,0.00087381696,0.0004374496,0.00011139451,0.000034077162,0.000107870495,0.0004324153,0.000004891932],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002171164,0.00069272466,0.00045245237,0.9883919,0.002942953,0.000063584666,0.000040726023,0.000004096491,3.8810177e-7,0.000016036913,0.0031577928,0.0042156577],"study_design_scores_gemma":[0.00022650132,0.0016669991,0.0005652757,0.9510619,0.024111668,0.00027547448,0.000032834596,0.0000029471112,0.0000015450152,0.0000051147927,0.021913499,0.0001362376],"about_ca_topic_score_codex":0.00020173333,"about_ca_topic_score_gemma":0.0000014574669,"teacher_disagreement_score":0.03732997,"about_ca_system_score_codex":0.00019750981,"about_ca_system_score_gemma":0.00031610037,"threshold_uncertainty_score":0.7545728},"labels":[],"label_agreement":null},{"id":"W3184137349","doi":"10.1007/978-3-030-70646-3_9","title":"Adjuvant Intravesical Therapy: Bacillus Calmette-Guerin","year":2021,"lang":"en","type":"book-chapter","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Epirubicin; Adjuvant; Bladder cancer; Immunotherapy; Mitomycin C; Urology; Pembrolizumab; Bladder tumor; Maintenance therapy; Oncology; Internal medicine; Surgery; Cancer; Chemotherapy; Breast cancer","score_opus":0.041737710216998215,"score_gpt":0.2944025851559552,"score_spread":0.25266487493895695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184137349","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00091959577,0.0917335,0.00006668049,0.0046309754,0.001980553,0.001480005,0.000788075,0.00024164986,0.89815897],"genre_scores_gemma":[0.0056859218,0.026438827,0.00019170149,0.0066270083,0.0033476832,0.00025460427,0.0003578099,0.0003293514,0.9567671],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971727,0.00002528995,0.0005258185,0.0009602578,0.0007586722,0.000557228],"domain_scores_gemma":[0.99826145,0.000044095323,0.00017546663,0.0008588603,0.00024209968,0.00041800193],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006997403,0.00078724715,0.001248457,0.0001512306,0.00009899212,0.0000482041,0.00018057489,0.00064684305,0.033130527],"category_scores_gemma":[0.0000124642065,0.0006450168,0.0005634767,0.00007315353,0.00020201238,0.000059414077,0.00009870131,0.0008336942,0.0004448078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016157256,0.00051375624,0.0005538809,0.0004852417,0.0084130075,0.003931984,0.0006692159,0.00000551602,0.0017064716,0.011617543,0.19684047,0.7736472],"study_design_scores_gemma":[0.0039605713,0.00053510343,0.0012550608,0.0007375415,0.00083043176,0.00017929672,0.000021350485,0.0000067919354,0.0019422827,0.000690513,0.9891267,0.0007143824],"about_ca_topic_score_codex":0.00030023375,"about_ca_topic_score_gemma":0.00015668523,"teacher_disagreement_score":0.7922862,"about_ca_system_score_codex":0.00048854115,"about_ca_system_score_gemma":0.001360583,"threshold_uncertainty_score":0.9996001},"labels":[],"label_agreement":null},{"id":"W3186207429","doi":"10.3233/blc-211536","title":"Muscle-Invasive Bladder Cancer in Patients with Liver Cirrhosis: A Review of Pertinent Considerations","year":2021,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Cirrhosis; Bladder cancer; Perioperative; Cancer; Incidence (geometry); Liver cancer; Population; Intensive care medicine; Internal medicine; Surgery; Gastroenterology","score_opus":0.0866534354349345,"score_gpt":0.3174134582990992,"score_spread":0.23076002286416472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186207429","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050069735,0.99415755,0.0000012424437,0.00043915314,0.00017583182,0.0037950876,0.0005099021,0.000028513845,0.00039201436],"genre_scores_gemma":[0.0009934076,0.99297065,0.0001492058,0.001105097,0.00018543616,0.0035550657,0.0005859823,0.000120231845,0.00033492944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99678975,0.00027065055,0.0011012667,0.00078032975,0.00061099697,0.00044699854],"domain_scores_gemma":[0.99760926,0.00020246606,0.0006078378,0.0006693966,0.0007011141,0.00020993785],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014759268,0.00068308914,0.0030282617,0.00026238075,0.00006257407,0.000022830814,0.00011280591,0.00029719574,0.00865492],"category_scores_gemma":[0.00014465764,0.0004823398,0.00073661166,0.0007064247,0.00010920766,0.000089658315,0.000078777586,0.00044524128,0.000027951844],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031588603,0.0011264281,0.06325425,0.21386822,0.0044351015,0.0004850599,0.00043783593,5.2475224e-7,5.279865e-7,0.000026284815,0.015686832,0.70064735],"study_design_scores_gemma":[0.0017574221,0.00024364887,0.004699817,0.45049003,0.011948354,0.000016747297,0.000022600416,0.0000032953894,0.000012173686,0.0000012689555,0.53022414,0.00058048946],"about_ca_topic_score_codex":0.0007371054,"about_ca_topic_score_gemma":0.0008192579,"teacher_disagreement_score":0.70006686,"about_ca_system_score_codex":0.0004933312,"about_ca_system_score_gemma":0.0035378633,"threshold_uncertainty_score":0.99976283},"labels":[],"label_agreement":null},{"id":"W4220766798","doi":"10.3233/blc-211653","title":"The Effect of Metformin on Bladder Cancer Incidence and Outcomes: A Systematic Review and Meta-Analysis","year":2022,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"ZonMw","keywords":"Meta-analysis; Metformin; Bladder cancer; Medicine; Oncology; Incidence (geometry); Cancer; Internal medicine; Systematic review; Urology; MEDLINE; Mathematics; Chemistry; Insulin","score_opus":0.040022150992179706,"score_gpt":0.361603022945861,"score_spread":0.3215808719536813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220766798","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029043791,0.9965561,0.0000037286854,0.00003725907,0.00014088476,0.00260787,0.000543799,0.000007699545,0.00007362875],"genre_scores_gemma":[0.000016700003,0.98846686,0.000007810713,0.00090716226,0.00006924811,0.009116961,0.00006367544,0.00006514869,0.0012864104],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962101,0.0010443124,0.0010530108,0.00082353555,0.00048558126,0.00038345892],"domain_scores_gemma":[0.99707365,0.0004795626,0.0010841353,0.0011593519,0.00007731285,0.00012596652],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014873159,0.0007323694,0.006418675,0.00012999054,0.00018903251,0.00005144765,0.00053625135,0.00022052023,0.000807708],"category_scores_gemma":[0.0003392596,0.00036885875,0.0021141183,0.000527987,0.00017542648,0.0000074105274,0.0003009701,0.00030331017,0.0000025502077],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015228098,0.000018575796,0.000016286027,0.544997,0.29427916,0.0000028212553,0.000031345942,0.00000497925,0.0000012860496,0.000022201833,0.002603119,0.158008],"study_design_scores_gemma":[0.00010363298,0.0000896301,0.0000014565954,0.002680017,0.4760908,0.0000036150984,0.0000068392214,7.3396376e-7,0.000023614746,0.0000020936423,0.5207249,0.00027265403],"about_ca_topic_score_codex":0.00020161555,"about_ca_topic_score_gemma":0.0003645989,"teacher_disagreement_score":0.542317,"about_ca_system_score_codex":0.000057945883,"about_ca_system_score_gemma":0.00025735862,"threshold_uncertainty_score":0.9998763},"labels":[],"label_agreement":null},{"id":"W4229034005","doi":"10.3233/blc-201534","title":"Systematic Review and Meta-Analysis on the Role of Perioperative Blood Transfusion in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma","year":2022,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Blood transfusion and management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Urothelial carcinoma; Medicine; Perioperative; Blood transfusion; Urology; Meta-analysis; General surgery; Oncology; Surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.01880628904969036,"score_gpt":0.2587386220342079,"score_spread":0.23993233298451752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229034005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.774068,0.1733329,0.0002416899,0.019727042,0.00011763627,0.029264366,0.0005421278,0.00004882183,0.002657398],"genre_scores_gemma":[0.9921828,0.0011309575,0.000032042783,0.0033027295,0.000007726742,0.002959456,0.000010310027,0.000014925573,0.0003590567],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9986803,0.00022392551,0.00038616938,0.000242625,0.00034104803,0.00012596132],"domain_scores_gemma":[0.99946976,0.000118690485,0.000087667024,0.0002335979,0.000048891572,0.000041384916],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003681879,0.00013155723,0.0010049111,0.00012436522,0.00011318282,0.0000065852014,0.00008097707,0.000020901729,0.0011574626],"category_scores_gemma":[0.000034452358,0.00007654182,0.0004102093,0.00036029503,0.000031768297,0.000019208806,0.000028722174,0.00012451429,4.291683e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024891475,0.0067296154,0.021712655,0.36536694,0.5613404,0.000039620445,0.021398768,0.00062141416,0.0019036136,0.017083233,0.00075162644,0.00056300435],"study_design_scores_gemma":[0.007954159,0.0014409608,0.003450068,0.0012481826,0.981366,0.0000038068076,0.0019902154,0.00034477588,0.001177018,0.000028262682,0.00075000426,0.00024659676],"about_ca_topic_score_codex":0.00020409873,"about_ca_topic_score_gemma":0.00030210827,"teacher_disagreement_score":0.4200256,"about_ca_system_score_codex":0.00003837615,"about_ca_system_score_gemma":0.00006315537,"threshold_uncertainty_score":0.9997556},"labels":[],"label_agreement":null},{"id":"W4242249173","doi":"10.3233/blc-200013","title":"Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Blockade; Immune checkpoint; PD-L1; Cancer research; Immune system; Medicine; Immunology; Immunotherapy; Internal medicine; Receptor","score_opus":0.01940299617668309,"score_gpt":0.30818444827895886,"score_spread":0.2887814521022758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242249173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9588474,0.012231906,0.00015145713,0.024644665,0.0003844633,0.0016958262,0.00023227949,0.00010863648,0.0017033527],"genre_scores_gemma":[0.99134696,0.0007678561,0.00075564877,0.0053007076,0.00021652858,0.0008234281,0.000018968005,0.00013170556,0.0006381806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99675703,0.00014954891,0.0008494579,0.00086516474,0.00065229635,0.00072649005],"domain_scores_gemma":[0.9983079,0.00007148162,0.0002132991,0.0006303097,0.00021179477,0.000565225],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023270395,0.0005070843,0.000928156,0.000281409,0.000056713172,0.000019427504,0.00029060311,0.00020247568,0.002088715],"category_scores_gemma":[0.00018643448,0.00046920445,0.0003259064,0.0012132208,0.00013833697,0.00012317003,0.00014625107,0.0003372235,0.000065527405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025268098,0.00039147164,0.012012707,0.00025461183,0.0014466982,0.0003155952,0.0034975288,0.0012021182,0.9394948,0.00001266838,0.0017173958,0.014386303],"study_design_scores_gemma":[0.01336518,0.001400508,0.15026991,0.0006875626,0.00061360927,0.000017165807,0.00085560314,0.0002780087,0.80615723,0.000045575398,0.025554119,0.0007555526],"about_ca_topic_score_codex":0.002604232,"about_ca_topic_score_gemma":0.00031262072,"teacher_disagreement_score":0.1382572,"about_ca_system_score_codex":0.00046865136,"about_ca_system_score_gemma":0.0010383445,"threshold_uncertainty_score":0.99977595},"labels":[],"label_agreement":null},{"id":"W4242864454","doi":"10.3233/blc-219500","title":"Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer","year":2021,"lang":"en","type":"erratum","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Blockade; Immune checkpoint; PD-L1; Bladder cancer; Medicine; Cancer research; Immune system; Oncology; Cancer; Internal medicine; Immunotherapy; Immunology; Receptor","score_opus":0.014289048765207263,"score_gpt":0.31194671665820956,"score_spread":0.2976576678930023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242864454","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4238751,0.44175947,0.00015535427,0.028432177,0.043965716,0.010255306,0.004294966,0.0004620174,0.046799928],"genre_scores_gemma":[0.39556274,0.054061983,0.0027440523,0.011582828,0.00582117,0.012403631,0.0022119284,0.002171818,0.5134399],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932056,0.00037242868,0.001712294,0.0018682351,0.001448963,0.0013924576],"domain_scores_gemma":[0.99603164,0.000120850884,0.00064442155,0.0018770549,0.00067700923,0.0006490481],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0004888209,0.0013257762,0.0025642137,0.0010015197,0.000101047764,0.000053441217,0.00058567396,0.0011413774,0.005223653],"category_scores_gemma":[0.00031819253,0.0012820438,0.00093369634,0.0019012613,0.0002604261,0.00013571887,0.00035867817,0.0014858431,0.000058181846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03955884,0.0022290016,0.0033761696,0.002942052,0.013770023,0.0037822365,0.0040305895,0.000853798,0.46416786,0.000015077945,0.4335121,0.031762265],"study_design_scores_gemma":[0.016598849,0.0014930757,0.064800054,0.009719485,0.0031783993,0.000096516116,0.001099746,0.000084262305,0.2503734,0.00006660856,0.65003294,0.0024566315],"about_ca_topic_score_codex":0.008060333,"about_ca_topic_score_gemma":0.0026427791,"teacher_disagreement_score":0.46663994,"about_ca_system_score_codex":0.0018659527,"about_ca_system_score_gemma":0.0065733,"threshold_uncertainty_score":0.99994934},"labels":[],"label_agreement":null},{"id":"W4323355305","doi":"10.3233/blc-220076","title":"An Association Study of Germline Variants in Bladder Cancer-Related Genes with the Prognosis of Non-Muscle Invasive Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Radboud Institute for Health Sciences; Radboud Universitair Medisch Centrum; Radboud Universiteit","keywords":"Bladder cancer; Germline; Cancer; Medicine; Gene; Oncology; Internal medicine; Biology; Genetics","score_opus":0.021976307643931308,"score_gpt":0.3163861492073973,"score_spread":0.294409841563466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323355305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912587,0.0020117713,0.000005170982,0.002350737,0.00042734735,0.0030532714,0.00034371237,0.00012248117,0.00042680049],"genre_scores_gemma":[0.9922885,0.0028335494,0.000046887242,0.0004172372,0.00032965743,0.0027223027,0.00005178822,0.00012356679,0.0011865178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99640775,0.00021999802,0.00082571065,0.00076968654,0.0010737,0.0007031364],"domain_scores_gemma":[0.9976036,0.000192718,0.0006878656,0.000667264,0.00066634244,0.00018220974],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043657978,0.00048318456,0.0009556526,0.00036018057,0.00014649318,0.00003042423,0.0003345846,0.0002599461,0.0010757988],"category_scores_gemma":[0.000041712028,0.00033175386,0.00014785015,0.0021067662,0.0001196808,0.00026308678,0.00008401776,0.00038797862,0.000014347289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000745496,0.0033291108,0.9328531,0.0002489287,0.0054843873,0.00007875192,0.020693665,0.003018966,0.015271319,0.0000056757867,0.005317079,0.012953511],"study_design_scores_gemma":[0.010029336,0.0018193861,0.9681223,0.00044934987,0.0020805139,0.0000027458768,0.004895707,0.00074994157,0.010999221,0.000020022375,0.00042537323,0.0004060945],"about_ca_topic_score_codex":0.030001147,"about_ca_topic_score_gemma":0.046359614,"teacher_disagreement_score":0.0352692,"about_ca_system_score_codex":0.0006039565,"about_ca_system_score_gemma":0.0015226275,"threshold_uncertainty_score":0.99991345},"labels":[],"label_agreement":null},{"id":"W4381381711","doi":"10.3233/blc-230028","title":"Association of Histone H3 Trimethylation in Circulating Monocytes with Lack of Early Recurrence in Patients with Bladder Cancer following BCG Induction Therapy","year":2023,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Immune responses and vaccinations","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Southeastern Ontario Academic Medical Organization; Canadian Institutes of Health Research","keywords":"Bladder cancer; H3K4me3; Medicine; Epigenetics; Histone; Cancer research; Internal medicine; Immunology; Oncology; Biology; Cancer; Gene; Gene expression; Promoter; Genetics","score_opus":0.03489865339660434,"score_gpt":0.3306919629090061,"score_spread":0.29579330951240174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381381711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969737,0.0021033227,0.000021620532,0.00015509404,0.0002644256,0.00038731963,0.000024628504,0.000020759868,0.000049137976],"genre_scores_gemma":[0.99893856,0.0003136355,0.00002840134,0.000013688035,0.000011349028,0.000105092324,0.00005437155,0.000017522525,0.0005173719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998932,0.00018427911,0.00035008023,0.00020979227,0.0000940331,0.0002298039],"domain_scores_gemma":[0.99918395,0.00014139552,0.0003751543,0.00012944499,0.0001624898,0.0000075436255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029952708,0.00012531893,0.00027812977,0.0003318407,0.000056652392,0.0000056032495,0.00007550126,0.0001560295,0.000102833226],"category_scores_gemma":[0.000059411886,0.000105637766,0.000046283996,0.0009159078,0.00002913705,0.0001984758,0.000016429622,0.00019640278,0.0000039275906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006146496,0.00012329046,0.95120656,0.000015290749,0.00029572583,3.9670192e-7,0.0026925115,0.0010590397,0.021310156,0.000013427831,0.00010399475,0.022564966],"study_design_scores_gemma":[0.004022824,0.00021865888,0.98231775,0.00018088023,0.000036289952,1.38088e-7,0.00024362921,0.0000313161,0.012642091,0.000020621732,0.0001560903,0.00012968777],"about_ca_topic_score_codex":0.004360944,"about_ca_topic_score_gemma":0.0011248459,"teacher_disagreement_score":0.031111222,"about_ca_system_score_codex":0.0002777663,"about_ca_system_score_gemma":0.00019433304,"threshold_uncertainty_score":0.6592472},"labels":[],"label_agreement":null},{"id":"W4386634361","doi":"10.3233/blc-230056","title":"Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"EMD Serono; National Cancer Institute; Natera; Medac; Astellas Pharma; Eisai; Genentech; UroGen Pharma; National Institutes of Health; Incyte; Bristol-Myers Squibb; AstraZeneca; University of Texas MD Anderson Cancer Center; Pfizer; Patient-Centered Outcomes Research Institute","keywords":"Bladder cancer; Medicine; Food and drug administration; Clinical trial; Drug; Intensive care medicine; Oncology; Clinical research; Cancer; Internal medicine; Pharmacology","score_opus":0.11651621659017142,"score_gpt":0.41965319554556235,"score_spread":0.30313697895539093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386634361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90209085,0.007671253,0.012324014,0.02005276,0.021694362,0.02507317,0.0014441548,0.0017474686,0.007901952],"genre_scores_gemma":[0.9035039,0.012219199,0.006320772,0.01414878,0.017226469,0.019412976,0.00026662846,0.00059689255,0.026304381],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99665046,0.00011004874,0.00081072806,0.0009296883,0.0005100403,0.000989058],"domain_scores_gemma":[0.9976908,0.0007224074,0.00023452686,0.0005823119,0.00031118505,0.00045875914],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000628396,0.00044579958,0.0008772585,0.0002000967,0.00024524174,0.000049399565,0.00022338607,0.00030797452,0.0015604034],"category_scores_gemma":[0.0003723881,0.00037911182,0.000525059,0.00062911195,0.00014489138,0.0001918187,0.00006802739,0.000340813,0.00024485224],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060748532,0.0010969595,0.011052188,0.00044727259,0.0037285083,0.0001951646,0.0016274855,0.0008183431,0.0049027493,0.00004569736,0.758916,0.15642107],"study_design_scores_gemma":[0.4545351,0.015249015,0.0902105,0.0019006637,0.0063450877,0.000033066706,0.0020330995,0.004645126,0.031438157,0.001720132,0.38904807,0.0028419674],"about_ca_topic_score_codex":0.0006553889,"about_ca_topic_score_gemma":0.0006308647,"teacher_disagreement_score":0.39378658,"about_ca_system_score_codex":0.00033622104,"about_ca_system_score_gemma":0.0023890296,"threshold_uncertainty_score":0.99986607},"labels":[],"label_agreement":null},{"id":"W4392599278","doi":"10.3233/blc-230082","title":"Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"National Cancer Institute","keywords":"Clinical trial; Bladder cancer; Biomarker; Medicine; Prioritization; Biomarker discovery; Translational research; Cancer; Intensive care medicine; Oncology; Internal medicine; Pathology; Proteomics; Biology; Business","score_opus":0.39942668439411855,"score_gpt":0.5273932410810593,"score_spread":0.1279665566869408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392599278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8593504,0.104747325,0.00054859614,0.012962967,0.00990675,0.008071548,0.0010677731,0.0004417337,0.002902951],"genre_scores_gemma":[0.9544129,0.025074283,0.0004283788,0.0027073792,0.003832715,0.006640648,0.00010796165,0.00022086735,0.006574876],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99503046,0.0003815679,0.0018350442,0.00128973,0.0006139663,0.0008492008],"domain_scores_gemma":[0.9960817,0.002211079,0.00031448418,0.00058641925,0.00051398366,0.0002923229],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002352829,0.0006158742,0.0016569995,0.00042775628,0.00016144718,0.00013334914,0.00024388131,0.0004039089,0.0013982884],"category_scores_gemma":[0.0013799344,0.00047911197,0.0007050429,0.000805017,0.00028202854,0.0005990722,0.00014069071,0.000488345,0.000055443787],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053271693,0.0017564093,0.19325174,0.0057666707,0.02713272,0.0006125223,0.010478547,0.000351451,0.013902392,0.00027645033,0.39721432,0.3439296],"study_design_scores_gemma":[0.04614606,0.002530938,0.57292706,0.013786932,0.011993703,0.00006453663,0.005672975,0.008789027,0.029177465,0.0041447566,0.30131716,0.003449407],"about_ca_topic_score_codex":0.001973979,"about_ca_topic_score_gemma":0.0042653163,"teacher_disagreement_score":0.3796753,"about_ca_system_score_codex":0.00062377204,"about_ca_system_score_gemma":0.0017232399,"threshold_uncertainty_score":0.99976605},"labels":[],"label_agreement":null},{"id":"W4396793480","doi":"10.3233/blc-230086","title":"Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy","year":2024,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Bladder Cancer Advocacy Network","keywords":"Cystectomy; Bladder cancer; Lymph node; Stage (stratigraphy); Medicine; Oncology; Center (category theory); Urology; Disease; Cancer; Internal medicine; Chemistry; Biology","score_opus":0.018474022223185543,"score_gpt":0.2928376693453191,"score_spread":0.2743636471221335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396793480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98954827,0.0041818772,0.00033753912,0.0007408644,0.00043675822,0.0015344822,0.0028441919,0.000104835795,0.00027117183],"genre_scores_gemma":[0.99613196,0.00073442736,0.0003078358,0.00046738272,0.00015533253,0.00049296825,0.00020554393,0.00010469497,0.0013998618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973016,0.000091672344,0.0004515433,0.0008828954,0.00073758897,0.0005346945],"domain_scores_gemma":[0.99876916,0.00004889226,0.00007714154,0.0004144897,0.00015663603,0.00053366646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010608139,0.00045246715,0.0006610187,0.0002229808,0.000065170854,0.000054686312,0.00011718095,0.0001277287,0.0007067816],"category_scores_gemma":[0.000009075722,0.00033737594,0.000109160304,0.00047520385,0.00017656738,0.00015172022,0.000080006714,0.00024473717,0.000008048644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016960812,0.0013606217,0.9885531,0.00032978528,0.00077583414,0.00012089501,0.00029348442,0.000036542788,0.00055041804,0.000008249478,0.0036948516,0.0025801158],"study_design_scores_gemma":[0.016130524,0.00031283236,0.9725801,0.0009476415,0.0004017573,0.0000026141674,0.000047341804,0.0007001275,0.00048658476,0.0000014738717,0.0080389045,0.00035010566],"about_ca_topic_score_codex":0.0020745106,"about_ca_topic_score_gemma":0.00060140324,"teacher_disagreement_score":0.015973028,"about_ca_system_score_codex":0.00068467075,"about_ca_system_score_gemma":0.0005829264,"threshold_uncertainty_score":0.99990785},"labels":[],"label_agreement":null},{"id":"W4406400675","doi":"10.1177/23523735241304348","title":"North American study and meta-analysis evaluating performance of Bladder EpiCheck <sup>®</sup> , a FDA cleared test, in non-muscle invasive bladder cancer recurrence","year":2024,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Cystoscopy; Cytology; Urine cytology; Internal medicine; Meta-analysis; Urine; Urology; Prospective cohort study; Cancer; Gastroenterology; Urinary system; Pathology","score_opus":0.06489310274473702,"score_gpt":0.36296035896314255,"score_spread":0.2980672562184055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406400675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831534,0.012762862,0.000016084146,0.0007735971,0.0001098047,0.0020628506,0.00048269238,0.0000878426,0.0005508867],"genre_scores_gemma":[0.992968,0.0024053864,0.00035016012,0.00070239627,0.00021487343,0.0019135593,0.000038515333,0.00010937604,0.0012977382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955048,0.00020729958,0.0010438814,0.0013955188,0.0010652436,0.00078324135],"domain_scores_gemma":[0.9977154,0.0004221938,0.00032394435,0.0008184492,0.00040485023,0.00031517036],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005003731,0.0007032344,0.002145252,0.0007354576,0.00014633752,0.00009593366,0.00028516428,0.000113145026,0.0026117095],"category_scores_gemma":[0.00014799199,0.0005551412,0.0006293032,0.003673119,0.0003572073,0.00036576408,0.0001765883,0.0006183164,0.000033136417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043947148,0.0011964515,0.8355917,0.00057135645,0.1047531,0.00013902536,0.014486386,0.0049689147,0.00029571017,0.000001467344,0.0015903735,0.03596609],"study_design_scores_gemma":[0.0027255353,0.002533734,0.7909964,0.00013415731,0.1742386,0.000013542018,0.0030934154,0.024619417,0.0006950493,0.000008958342,0.00023262069,0.0007085681],"about_ca_topic_score_codex":0.014871093,"about_ca_topic_score_gemma":0.022966312,"teacher_disagreement_score":0.0694855,"about_ca_system_score_codex":0.0003522886,"about_ca_system_score_gemma":0.0011064885,"threshold_uncertainty_score":0.99969},"labels":[],"label_agreement":null},{"id":"W4407930482","doi":"10.1177/23523735251319185","title":"Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer <sup/>","year":2025,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Clinical trial; Bladder cancer; Medicine; Prioritization; Multidisciplinary approach; Task force; Genitourinary system; Cancer; Medical physics; Intensive care medicine; Internal medicine; Management science; Engineering","score_opus":0.5750571568378412,"score_gpt":0.5616935397453389,"score_spread":0.013363617092502333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407930482","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013987678,0.982034,0.000026217493,0.00078369136,0.0048868824,0.0064244266,0.0021220304,0.00005270547,0.0022712254],"genre_scores_gemma":[0.0007209451,0.97743,0.00017994283,0.0034108586,0.013548672,0.0026880598,0.00077489234,0.00015942908,0.0010872193],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9739099,0.012159601,0.010421345,0.0017465757,0.0010301579,0.00073242956],"domain_scores_gemma":[0.95440406,0.038732436,0.0047547575,0.0014125933,0.00033935354,0.000356824],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.021762524,0.0011273545,0.012720856,0.00037017534,0.00017547335,0.000108932305,0.00065003324,0.0016449208,0.0013865671],"category_scores_gemma":[0.022096619,0.0006903817,0.003950625,0.0008118849,0.00027129898,0.00015990315,0.00022919648,0.0021788047,0.000039916686],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008239477,0.0005001048,0.0031032017,0.0027214722,0.0054122824,0.00006335479,0.0003550773,0.000072803385,0.000015177234,0.0000068906265,0.0876458,0.8992799],"study_design_scores_gemma":[0.01444745,0.0008716155,0.0031095995,0.15501767,0.024965921,0.0000039882893,0.00039155866,0.00022845714,0.00009984972,0.00006155612,0.79966456,0.0011377604],"about_ca_topic_score_codex":0.0058428193,"about_ca_topic_score_gemma":0.0019823061,"teacher_disagreement_score":0.8981421,"about_ca_system_score_codex":0.0004989466,"about_ca_system_score_gemma":0.008996632,"threshold_uncertainty_score":0.99965113},"labels":[],"label_agreement":null},{"id":"W4415396380","doi":"10.1177/23523735251384859","title":"Bladder cancer journal as official IBCN partner; strengthening global collaboration in bladder cancer","year":2025,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; MEDLINE; Bladder tumor; Urinary bladder; Urinary Bladder Cancer","score_opus":0.01755985747081858,"score_gpt":0.37390173788908654,"score_spread":0.356341880418268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415396380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8634322,0.055864237,0.00038917342,0.025362551,0.008476531,0.0028511807,0.0010386909,0.00034013053,0.042245295],"genre_scores_gemma":[0.9664605,0.008407137,0.0002852162,0.0079793,0.0030875865,0.001270259,0.000064519845,0.0001187146,0.0123267155],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99552137,0.00019147842,0.0011023533,0.0009992432,0.0010013611,0.0011841943],"domain_scores_gemma":[0.99782157,0.00007979766,0.0003813555,0.0005580633,0.00071095355,0.0004482463],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029488344,0.00074652815,0.0010119018,0.0003912051,0.0004142746,0.000256801,0.00035769664,0.00046228134,0.0070132585],"category_scores_gemma":[0.00011475977,0.0006683461,0.00030523643,0.001989436,0.00022128636,0.00046179863,0.00012466974,0.0008279373,0.00007321892],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067968997,0.0022331872,0.4465956,0.00044806307,0.008342948,0.00078549347,0.005717186,0.007827242,0.0035644118,0.0025724627,0.27958193,0.23553456],"study_design_scores_gemma":[0.04837049,0.0015452266,0.3079964,0.0052292384,0.006865389,0.00026324886,0.0068254787,0.0029401854,0.021365361,0.004446474,0.5906851,0.0034673912],"about_ca_topic_score_codex":0.011723435,"about_ca_topic_score_gemma":0.029716928,"teacher_disagreement_score":0.3111032,"about_ca_system_score_codex":0.0025958128,"about_ca_system_score_gemma":0.007500093,"threshold_uncertainty_score":0.99957675},"labels":[],"label_agreement":null},{"id":"W4415924917","doi":"10.1177/23523735251395361","title":"Urothelial carcinoma and the potential clinical application of urinary extracellular vesicles: Current Status and prospects","year":2025,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Japanese Urological Association","keywords":"Urothelial carcinoma; Biomarker; Clinical Practice; Urinary system; Precision medicine; Personalized medicine; Carcinoma","score_opus":0.017959978658533222,"score_gpt":0.3387597059886518,"score_spread":0.3207997273301186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415924917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004991703,0.9923511,0.00056069036,0.00002241296,0.0002841624,0.0015226904,0.00020626176,0.000008050489,0.000052892057],"genre_scores_gemma":[0.015663227,0.982774,0.00008388712,0.000022755741,0.000598454,0.00045229294,0.00013744294,0.000038537157,0.00022938209],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979978,0.00029813268,0.0006391141,0.0006570479,0.00016063519,0.00024725727],"domain_scores_gemma":[0.9987529,0.000059481594,0.00039057957,0.0006058327,0.00006995586,0.000121235506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032151016,0.00031614688,0.00072181097,0.00004566704,0.00007409687,0.000027242291,0.00024927067,0.0002744785,0.000008887287],"category_scores_gemma":[0.00007703045,0.00022969084,0.00031402786,0.000096112024,0.00060848246,0.000003658226,0.0003445527,0.00026482836,0.0000015619727],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017807864,0.00016518675,0.00049198617,0.008502424,0.00023770863,0.0000049057935,0.000020003514,0.000001333851,0.0002563775,0.0004864222,0.00038067048,0.9892749],"study_design_scores_gemma":[0.0018498104,0.0001248407,0.00059720874,0.0014472096,0.0017301168,0.000017459435,0.00001597527,0.000061891886,0.00019540964,0.0002064169,0.9933737,0.0003799823],"about_ca_topic_score_codex":0.000026556796,"about_ca_topic_score_gemma":0.0000050465337,"teacher_disagreement_score":0.992993,"about_ca_system_score_codex":0.000020647265,"about_ca_system_score_gemma":0.00067008997,"threshold_uncertainty_score":0.936652},"labels":[],"label_agreement":null}]}